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Plethysmography refers to the dynamic measurement of biological tissue volumes that, 
for example, may change due to fluctuations in blood volume. Photoplethysmography (PPG) 
makes use of the attenuation of light penetrating into vascular tissues to determine these changes 
in blood volume. Modern PPG is an optical technique involving low cost photosensors and light 
emitting diodes (LED), and is capable of measuring multiple biological vitals simultaneously. 
For example, in addition to heart rate determination, PPG devices can be used as pulse 
oximeters, capable of calculating the blood oxygen saturation (SpO2) through a series of simple 
optical calculations performed on either reflectance or transmittance data. In this project, a 
reflectance-based PPG pulse oximeter was designed to collect blood volume measurements on 
the foot of a patient. This project also involves using the PPG sensor to determine the effect of 
vibrational signal on vasoconstriction in the tissue, to provide more information on biological 
properties, including diabetic nerve damage. The device is constructed via dual wavelength light 
sources and a phototransistor where the light sources are determined based on the isosbestic 
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The development design and utilization of a photoplethysmography sensor will be discussed 
throughout the extent of this thesis. In America and throughout the world there is an increasing 
number of health concerns. Some of the most common diseases such as cancer, heart disease and 
diabetes, can be fatal and often require constant medical monitoring to ensure good health. As 
technology advances, monitoring and assessing health is becoming easier and more accessible. 
The development of point-of-care medical tools, capable of monitoring and providing instant 
results, have led to the advance in medicine. These, small, compact, and easy to use medical 
devices can provide quick and easy monitoring of vitals as well as provide instant results for 
more advanced monitoring. Similarly, medical devices that are non-invasive and do not require 
skin penetration excel above the rest due to the decrease risk of infection. Designing medical 
devices should incorporate all of the described characteristics and should provide a tool that 
makes medical diagnostics and monitoring easier and more convenient.  
 
Diabetes, a major medical disease and a growing concern in the United States, is incurable and if 
not treated appropriately can lead to adverse health effects. Continuous monitoring of the disease 
is necessary to track patient’s health and monitor degradation. One of the most common effects 
of diabetes is nerve damage and degradation. An electronic tuning fork can be used to determine 
nerve damage caused by prolonged untreated diabetes. The tuning fork is an example of a 
medical device that can be utilized remotely and provide accurate instant results. There are many 
other medical devices widely utilized in the medical field, that monitor and evaluate vitals. The 
ease of use of the device and the time to results are critical when it comes to the effectiveness of 
these tools.  
 
An electronic tuning fork is utilized as a point of care medical tool to evaluate nerve damage, in 
diabetic patients. The project goal is to incorporate a blood oxygen sensor into the electronic 
tuning fork, developing a device capable of evaluating the nerve damage and blood oxygen 
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levels. The device becomes more critical to doctors as it now provides two medical statistics 
instantaneously.  Throughout the extent of this thesis the design and development of a blood 
oxygen sensor to incorporate into the electronic tuning fork, will be discussed in detail. The 
oxygen sensor is designed optimize the signal and provide doctors with more accurate results. 
The combined device will be beneficial to the medical field, and give doctors a faster and easier 
way to tests and evaluate patient health.  
 
1.1 The Importance of Medical Device Technologies 
As technology advances in all fields of science, the development of more versatile and compact 
medical diagnostic devices becomes available. Measuring biological vitals such as heart rate, 
body temperature and blood pressure are important indicators of one’s health. A specific 
example of vital sign abnormality is heart rate variation, which can be an indication of many 
health concerns such as, the effects of disease, chemical imbalances, or other biological 
abnormalities. Monitoring heart rate can provide an indication of detrimental clinical health 
events, such as heart failure, or abnormal heart rates (e.g. Tachycardia, Arythmias, or premature 
contractions). If a patient is experiencing a continuous heart rate above 100 beats per minute, this 
is faster than normal, and known as tachycardia[1]. Monitoring patient vitals can be critical to 
determining health and can indicate serious medical abnormalities. According to a number of 
studies, changes in vital signs occur several hours before a serious adverse event[2]. It is 
important to constantly monitor vital signs; heart rate was provided as an example, but all health 
statistics are useful in determining the health of a patient. The importance of monitoring vital 
signs is evident, but the frequency and how best to monitor them is often disputed[2].  A study 
performed at a hospital in England determined that 31% of preventable deaths were a result of 
poor clinical monitoring[3]. Providing easy to use medical devices capable of monitoring vitals 
could lead to, earlier indication of a critical event, more extensive monitoring of disease 
progression, and better prolonged tracking of ill patients.  
 
Diabetes causes degradation in many systems throughout the body, the disease is a result of high 
blood sugar which can lead to kidney failure, destruction of blood vessels and nerve damage. 
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The disease causes severe autonomic dysfunction leading to sudden cardiac death, continuous 
monitoring of heart rate can decrease this risk[4]. Many diseases can cause heart failure, often 
seen as abnormalities in heart rate, leading medical device companies to explore a number of 
approaches to continuous monitoring of vitals [1]. Over time this has resulted in increased device 
mobility and utility, tending towards decreased size and complexity.  
 
Handheld devices such as personal digital assistants (PDAs) have become increasingly popular 
in the medical field[5]. Many PDAs involve recording and tracking information at point-of-care 
testing, allowing medical data to be stored throughout patient interaction. Point of care (POC) 
technologies have increased in popularity over the last 40 years, due to the changes in health care 
to deliver convenient and cost effective aid[6]. Most POC technologies are chemical diagnostic 
testing, such as blood glucose or other handheld fluidic testing devices, these usually require a 
finger prick or some invasive measure to acquire the biological material for testing. More 
popular POC devices include non-invasive technologies such as pulse oximeters, breathalyzers 
and other biological monitoring devices[7]. These compact non-invasive POC medical devices 
support growth in biological monitoring technologies. New non-invasive medical monitoring 
technologies give doctors easy to use testing devices with rapid results.   
 
1.1.1 The Combination of Medical Devices to Advance Patient Care 
As POC, and other medical devices become more capable, there is an increasing number of tools 
utilized to monitor and measure vital signs.  Doctors will often evaluate multiple tests and vital 
monitoring to get a more in depth understanding of the patient’s health. There are usually 
multiple devices needed to collect different vital statistics. For example, heart rate is measured 
using an ECG, blood pressure with a pressure cuff, temperature with a thermometer, etc. 
Combining various medical devices to incorporate all monitoring at once, not only reduces 
monitoring time, but provides paralleled medical results.  For example, there are benefits of 
monitoring blood oxygen and heart rate simultaneously, as the blood oxygen decreases, heart 
rate might increase in attempts to provide more oxygen to the body. Measuring multiple vitals 
simultaneously provides doctors with more diagnostic information without needing to preform 
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multiple tests. A study evaluating patient vital signs found that patients with one abnormal value 
had an in-hospital mortality rate of 0.9% but if the patient had three abnormal values they had an 
in-hospital mortality rate of 24%[3]. Combining medical devices to monitor an assortment of 
biological vitals is efficient but difficult to execute. It is challenging to design a single accurate 
medical device with two separate devices that have varying points of contact, different biological 
collection processes and inconstant data acquisition techniques. All of those differences are 
important when designing handheld medical devices with numerous medical capabilities.  
 
1.2 Diagnostics for Diabetic Neuropathy 
Neuropathy of the lower extremities resulting from diabetes is a growing concern in the US with 
serious consequences. According to the CDC, 26.9 million people in the United States have been 
diagnosed with diabetes[8]. A result of prolonged untreated diabetes is neuropathy, where the 
nerves degrade due to lack of blood flow from increased blood glucose levels.  Diabetic 
neuropathy usually starts as a loss of sensation in the extremities but can manifest into pain and 
inability to judge temperature. Further nerve damage can lead to atrophy (loss of muscle) in 
lower extremities resulting in loss of function and deformation[9].  Diabetic neuropathy is an 
extremely common disease, research suggests about 50%  of those diagnosed with diabetes will 
develop peripheral neuropathy[6]. It is also suggested that it is impossible to accurately 
approximate the prevalence of the disease due to the variation in diagnostic criteria.  A common 
practice for evaluating diabetic neuropathy involves vibratory sensation, where a 128-Hz tuning 
fork is held on the bottom of the foot. An abnormal response is recorded when the patient loses 
sensation and the examiner can still feel the vibration, the examiner will give a score between 0 




Figure 1.1: [A] Percentage of US population diagnosed with diabetes from 1958-2015. [B] Number of US population diagnosed 
with diabetes from 1958-2015. Image reproduced from [12] 
Because diabetes is one of the most common diseases there are many methods to indicate how 
the disease is advancing in the body. As we discussed above neuropathy is a significant adverse 
effect of the disease measurable by a vibrational signal. Another result of diabetes is degradation 
of blood oxygen to the peripherals. Diabetes causes blood flow to decrease and many of the 
extremities to lose blood circulation, leading to the neuropathy. It is important to monitor blood 
oxygen in the extremities to evaluate the degradation of blood circulation. The combination of a 
tuning fork utilized on the foot of a diabetic patient that is also capable of monitoring the blood 
oxygen would be beneficial to further understand the extent of the diabetes in the patient. 
 
1.3  Project Specific Aims 
The Electronic Tuning Fork (ETF) is an example of a handheld medical sensor that can deliver 
POC diagnostics to a patient. The device is used to test the extent of neuropathy (damaged 
nerves) in patients who have diabetes. The ETF produces quantitative data to the extent of nerve 
damage and eliminates testing with tuning forks. The device is a small compact instrument that 
vibrates at specific frequencies, similar to the mechanical tuning forks. The ETF device is placed 
on the foot at a high vibrational amplitude, and slowly decreases until the patient can no longer 
feel the vibration. The time at which the patient lost vibrational sensation is recorded and 
represents the extent of nerve damage. The ETF provides a controlled and accurate way to define 
nerve damage. The device is designed to quantify the nerve damage and eliminate variation, seen 
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with the mechanical tuning fork, across doctors. Adding more medical diagnostic tools to the 
ETF would advance the device potential and usability in POC treatment.  
 
Todd O’Brien, DPM the founder of O’Brien Medical LLC, launched the first Electronic Tuning 
Fork (ETF128) in 2015 and now has the more advanced ETFMX. O’Brien Medical LLC was 
looking to advance the ETF by addition of a blood oxygen monitor to the device. O’Brien 
connected with the University of Maine Bioengineering program to advance his device. I was 
tasked with the project to develop a blood oxygen sensor that could integrate into O’Brien’s 
electronic tuning fork. 
 
Aim 1: The first goal of the thesis is to design a pulse oximeter to fit into the ETF, allowing the 
examiner to collect information on the patients’ diabetic nerve damage and blood oxygen 
saturation simultaneously using a single device. Construction of an operational blood oxygen 
sensor requires reverse engineering of current pulse oximeters and evaluation of optimal optical 
components. Research and evaluation of optical physics and light attenuation utilized to evaluate 
oxygen saturation in the blood is necessary to ensure accurate device construction.  After 
research, optimal optical components, and device design are determined. The design of the 
device must allow for integration into the ETF. Further construction requires development of 
PPG boards created with the help from electrical engineers.  
 
Aim 2: After designing an accurate blood oxygen sensor into the ETF, the final goal was to 
redesign the tuning fork cap to optimize the designed sensor. This involves research and 
understanding of light and it’s physical properties through dermal material. The goal was 
designing a mechanical covering to optimize the amount of light that was penetrating into the 
skin and returning to the sensor. Testing requires changing the direction of light using various 
caps and evaluating the returned signal. 3D-printed caps must be designed to direct the light in 






For the body to maintain homeostasis, all biological components need to be preforming 
optimally adjusting to conditions and aiming for stability. There are many aspects of human life 
that can be monitored to determine the state of homeostasis for an individual, such as vital signs 
which are biological processes that can be observed. Therefore common vital signs are 
temperature, blood pressure, heart rate (pulse) and respiratory rate. Other vital signs include 
blood glucose levels, oxygen saturation, and pain. For example, a decrease in pulse, oxygen 
saturation or temperature can indicate the human body is not operating correctly. If this data is 
not captured quickly enough, further degradation can occur. This indicates that constant 
monitoring of vitals can be crucial for saving lives. There are many ways to monitor vitals, 
which have evolved over the years as technologies have likewise advanced.  Today, there are a 
multitude of sensors utilized in medical facilities to provide constant monitoring of critical 
biological vitals.  
 
Photoplethysmography(PPG) is an optical signal utilized in medical devices to monitor the heart 
rate. The signal is a technique that has become popular across the advancing medical technology 
field and is utilized across most hospitals today. PPG signal technique is applied in pulse 
oximeters, by means of light absorption and reflection through biological tissues. As the heart 
pumps blood throughout the body, it carries oxygen from the lungs to the tissues, and a pulsatile 
signal can be generated from obstruction of light due to increased blood flow. The PPG signal is 
a waveform which reflects the eb and flow of the heart pumping blood. The PPG signal is 
derived from Beer’s law, where the incident of light exiting a material is proportional to the light 
entering and the optical characteristics of the material itself.  
 
Understanding the biological and optical components of blood, as well as the components needed 
to optically record blood volume changes, a PPG signal can be generated.  The PPG waveform is 
utilized in pulse oximeters and is capable of determining the difference between oxygenated and 
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deoxygenated blood, thus providing blood oxygen saturation.  The PPG signal utilized in pulse 
oximeters is a critical tool to monitor and evaluate the health of an individual.  
 
2.1 Significant Anatomy   
Oxygen(O2) is a vital element to the human body, without it, homeostasis is not maintained, and 
cells will begin to deteriorate. The process of supplying the body with oxygen relies on gas 
exchange, which first occurs within the respiratory system, where pressure differences in the 
lungs cause oxygen to be inhaled. Oxygen enters the blood and is transported throughout the 
body by means of the heart. The pumping action by specific chambers in the heart facilitates the 
movement of oxygenated blood from the lungs into the blood vessels, to transport it throughout 
the body. The heart is a vital organ that is capable of self-regulating to the body’s cardiac output 
needs. The heart pumps blood from the lungs into first the arteries then the arterioles and finally 
capillaries. Once the oxygenated blood reaches the capillaries gas exchange occurs and oxygen 
from the red blood cells (RBCs) is transferred to the tissues. 
 
2.1.1 Blood and Circulatory System 
Blood makes up about 8% of the human body and aids in numerous functions to maintain 
homeostasis, including regulation of pH, maintaining body temperature, and transportation of 
vital nutrients throughout the body[13], [14].   Blood consists of two principal components, 
plasma and formed elements depicted in figure 2.1.  Plasma makes up about 55% of the blood, 
and the formed elements account for the remaining 45%.  The plasma portion of the blood is a 
water-based a yellowish fluid that contains <10% of plasma proteins, such as albumin, and other 
solutes[13], [14]. Of the formed elements in the blood, 95% are red blood cells (RBCs), the other 
5% are white blood cells (WBCs) and platelets[14].  The WBCs provide protection against 




Figure 2.1: Separation of blood, and approximate values of components in a normal adult. 
 
Erythrocytes, or red blood cells (RBCs), primary functions are delivery of O2 to tissues and 
removal of carbon dioxide(CO2) as waste[13].  RBCs shape is similar to a flat disc, but the 
outside edges are thicker than the inside center to increase the cell’s surface area. The greater 
surface area allows O2 and CO2 to diffuse across the tissues more rapidly and the thin center adds 
flexibility to pass through smaller blood vessels[13], [14].  RBCs transport approximately 98.5% 
of the O2 in the blood to the tissues, the other 1.5% is dissolved in the blood plasma[14].  
 
The main component of RBCs is hemoglobin (Hb), which gives the cell the ability to transport 
oxygen. The hemoglobin molecule consists of four globin protein chains, each chain contains a 
non-protein heme group illustrated in figure 2.2.  Iron, in the heme, facilitates the binding of 
oxygen (O2) molecules to the RBCs, because the hemoglobin molecule contains four irons it has 
the capacity to bind four O2 molecules to each hemoglobin molecule[13]. Hemoglobin on the 
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RBCs collect oxygen in the lungs and transport the gas to the tissues through the blood vessels. 
Once the oxygenated RBC reaches the systemic capillaries the O2 molecule is released and a 
CO2 molecule is collected. The RBC with bound CO2 then travels back through the blood vessels 
to the lungs where the CO2 is exhaled[13]–[15].  
 
When oxygen is bound to hemoglobin it is referred to as oxyhemoglobin(HbO2) and has a bright 
red appearance[14]. Another form of hemoglobin is deoxyhemoglobin (Hb) where no oxygen is 
bound to the heme group on the RBC. Some hemoglobin molecules have lost the ability to bind 
oxygen and lead to limited oxygen supply.    
 
Figure 2.2: The Red blood cell is comprised of a hemoglobin molecule which contains 4 chains each with an iron group. The iron 
group on the chains binds to the oxygen in the lungs and transports it to the tissues. 
 
All tissues utilize O2 to operate and perform biological tasks, because of this RBCs are vital to 




2.1.2 Respiratory System 
The respiratory system in the body consists of an upper respiratory tract and a lower respiratory 
tract.  The upper tract consists of the external nose, nasal cavity, pharynx, and associated 
structures, and the lower respiratory tract includes the larynx, trachea, bronchi, and lungs[13], 
[14].   Humans have two lungs located below the ribs in the upper trunk of the body.  Each lung 
is branched off into lobes called lobar bronchi, which are further segmented into bronchioles, 
terminal bronchioles and finally alveoli[14].  Alveoli are small air filled chambers that facilitate 
gas exchange in the blood[14].  
 
Figure 2.3: Anatomy of the lungs; two lungs a left and a right are separated from the trachea by the bronchi, within the lungs the 
bronchi segregate into bronchioles, leading to the alveoli. The alveoli are responsible for the gas exchange between lungs and 
the blood, facilitating CO2 removal from blood to be exhaled and diffusion of O2 inhaled into the blood. 
 
 
Ventilation, the process of moving air in and out of the lungs, is divided into inhalation and 
exhalation[14], [15]. Respiratory ventilation is governed by principles of flow and pressure, the 
difference between the external pressure (atmospheric) and the pressure inside the lungs 
(intrapulmonary pressure) drives inhalation and exhalation[13].  Air enters the body and travels 
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through the lungs into the alveoli, where the O2 readily transfers into the blood and CO2 transfers 
from the blood to the lungs to be exhaled[13]. The alveoli have a thin membrane surrounded by 
pulmonary capillaries containing deoxygenated blood[15].  The transfer of gasses, or gas 
exchange is driven by the physics of partial pressure, where elements will flow to maintain 
equilibrium[13].  After inhalation the partial pressure of oxygen (Po2) is higher in the alveoli 
then in the surrounding capillaries, thus driving the diffusion of oxygen from the lungs into the 
blood[16]. The reverse will happen for the CO2 where the partial pressure of CO2 (Pco2) in the 
lungs is lower than the Pco2 in the blood, thus the CO2 from the blood will flow into the lungs 
and be exhaled[16].  
 
Oxygen travels from the lungs into the blood and binds to the hemoglobin, once bound the 
oxygen is carried to the tissues where it released it in the systemic capillaries[15].  The 
hemoglobin binds or disassociates with the oxygen molecule depending on the surrounding 
partial pressure of oxygen[14].  In the systemic capillaries the Po2 is lower than the Po2 of the 
blood, causing the O2 molecule to disassociate with the hemoglobin and move into the tissue. 
Partial pressure of oxygen and hemoglobin oxygen saturation (So2) depict the bodies ability to 




Figure 2.4: The oxygen-hemoglobin dissociation curve. Representing a healthy subject with a normal blood hemoglobin (Hb) 
concentration. The y- axis represents the hemoglobin saturation as a percentage, and the x-axis shows the partial pressure of 
oxygen in the blood. The Hb is highly saturated when the PO2 is at high, and when the PO2 is low the Hb saturation is low. The 
correlation is not and when the PO2 is high the Hb saturation does not change significantly, but when the PO2 declines the 
hemoglobin saturation fall rapidly. Image reproduced from[16]. 
 
The saturation of oxygen (So2) is relative to the number of binding sites on a hemoglobin 
molecule[16]. Consequently, A hemoglobin macromolecule that is 100% oxygenated indicates 
that all four binding sites on the hemoglobin molecule are bound to oxygen, if only two O2 
where bound the hemoglobin would be 50% and so on[13]. The oxygen-hemoglobin dissociation 
curve illustrates the percent saturation of hemoglobin to the partial pressure of oxygen shown in 
figure 2.4. Generally when the Po2 increases this is followed by a rise in the oxygen 
saturation(So2) [16]. Because the dissociation curve is considerably flat when the Po2 is greater 
than 90%, an increase in Po2 has minimal effects on the hemoglobin saturation. In contrast when 
the Po2 is below 90% the hemoglobin saturation drops substantially[16].  The optimal oxygen 




2.1.3 Cardiovascular System 
The cardiovascular system along with the circulatory system are responsible for the movement of 
blood through the body. The heart pumps oxygenated blood from the lungs to blood vessels 
which travel throughout the body to deposit oxygen. The heart and blood vessels are capable of 
regulating blood flow and optimizing oxygen transportation.  
 
The heart consist of four chambers, two ventricles and two atria, left ventricle and left atria and 
right ventricle and right atria[13]. The ventricles are responsible for pushing blood out of the 
heart to the connecting arteries, thus the ventricles are of greater muscle mass than the atria.  The 
left side of the heart acquires oxygenated blood from the lungs and pumps it throughout the 
body, whereas the right side of the heart obtains returning deoxygenated blood and pumps it to 




Figure 2.5: Anatomy of the heart, the left atrium fills with blood from the lungs and travels into the left ventricle, the two 
chambers are divided by the mitral valve. The left ventricle is responsible for contracting and forcing blood throughout the body. 
On the right side of the heart is the right atrium, responsible for collecting returned blood with CO2, and the right ventricle. The 
right chambers are divided by the tricuspid valve, the right ventricle contracts to send deoxygenated blood to the lungs to be 
exhaled. 
 
The cardiac cycle refers to the continuous pumping action of the heart and consists of a complete 
contraction and relaxation of all four chambers[13], [14].  The cardiac cycle describes the 
movement of blood through the heart and consists of multiple phases but is often divided into 
systole and diastole.  The terms systole and diastole refer to the contraction and relaxation of the 
ventricles [14].  Blood first enters the heart through the pulmonary veins, where blood 
oxygenated from the lungs flows passively into the left atrium. The first phase of the cardiac 
cycle is ventricular filling where the ventricles are relaxed (diastole) and the AV valves open 
causing blood from the atrium to flow into the left ventricle[13]. During ventricular filling the 
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atrium will contract to facilitate complete filling of the ventricle[13], [14]. At the end of this 
phase each ventricle contains an end-diastolic volume (EDV) about 130mL of blood[13]. The 
second phase in the cardiac cycle is isovolumetric contraction, where the atria relaxes, and the 
ventricles begin to contract.  The slight contraction of the ventricles causes the AV valves to 
close and cease the blood flow from the atrium to the ventricle[13]. This forceful closing of the 
AV valves and vibrations from this cause the first heart sound often referred to as a “Lub” [13], 
[14]. The third stage of the cardiac cycle is ventricular ejection commonly referred to as systole.  
In this phase the ventricles forcefully contract increasing the pressure beyond that of the 
connecting arteries.  The semilunar valves open and the blood in the ventricles is driven into the 
arteries, generating a spike in the aortic pressure[13].   
 
Not all of the blood in the ventricles is ejected into the arteries, the EDV is about 130mL and 
only about 70mL is expelled, this is known as the stroke volume (SV)[13].  The amount of blood 
left in the ventricle after total ventricular ejection is the end-systolic volume (ESV), about 54% 
of the blood is ejected into the arteries[13].  During high intensity exercise the percent ejection 
can be as high as 90%[13]. The final phase of the cardiac cycle is isovolumetric relaxation, 
where the ventricles enter diastole and relax.  As the ventricles relax a minimal amount of blood 
from the arteries flows back into the ventricles, this force prompts the semilunar valves to close 




Figure 2.6: Heart contraction Cardiac Cycle starts with the passive flow of blood into the atrium once the blood fills, the atrium 
contracts forcing blood into the ventricles, the valves between the atrium and the ventricles close and the ventricles begin to 
contract, when the ventricles contract blood is forced out of the heart and into the body. 
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As the heart pumps, cycling through the cardiac cycle, blood is forced into the arteries. When the 
left ventricle contracts blood is forced out of the heart and into the circulatory system via the 
aorta. The increased blood volume into the aorta forces blood throughout the body, this increases 
the volume not only at the arteries but throughout all of the circulatory system components. The 
blood volume throughout the body pulses with the beating of the heart, allowing for heart rate 
monitoring in all locations with constant blood supply, even the capillary beds.  
 
Variations occurring in the cardiac cycle, also known as arrhythmias, can be attributed to heart 
failures and lead to death. One benign example of this is premature ventricular contraction 
(PVC), which interrupts normal heartbeats and causes an irregular pulse. Although PVC can lead 
to more serious rhythm disturbances that are most often harmless, and detected as a miss beat or 
a “flip-flop” in the chest[17]. There are various other arrhythmias that are indications of harmful 




2.2 Review of Clinical Techniques for Monitoring Blood Perfusion Vitals 
Blood perfusion is necessary to sustain life, it is responsible for the transport of oxygen, nutrients 
and waste throughout the body[18].  Abnormalities in blood perfusion are used to identify and 
diagnose biological conditions, consequently monitoring this vital sign is important to sustained 
health.  Blood flow or blood perfusion can be utilized to monitor many vitals such as, heart rate, 
blood oxygen saturation and blood pressure.  
 
The observation of blood perfusion and blood monitoring techniques have been around for 
hundreds of years and are still utilized in modern medicine. The first measured heartbeat was 
said to have been discovered by Herophilus of Alexandria, Egypt (c. 335-280 BC) who designed 
a water clock capable of timing the pulse[19]. As technology and medical understanding 
advanced, so did the ability to monitor biological vitals and in the late 1800’s the first ECG was 
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discovered by physician Willem Elbthoven[19]. Since then, the monitoring of pulse and other 
blood perfusion vitals have advanced throughout medical history. Today technology has 




2.2.1 Clinical Applications of Heart Rate Monitoring 
The clinical need for compact, non-invasive, and easy to use, heart rate monitors has increased 
throughout medical history. Heart rate is the most important vital that can indicate biological 
failure, and although heart disease was the leading cause of death in the United States in 2017, 
there are many other diseases that affect heart rate[20]. Sudden cardiac death (SCD) accounts for 
25% percent of the deaths in cardiac patients, monitoring heart rate variability can indicate 
problems before death occurs[21].  
 
Heart rate is most frequently monitored using an EKG (ECG), in hospital settings, that records 
the pulsatile signals of heart contractions. Healthy heart beats are characterized as a “lub – dub” 
sound, but there are many instances where the heartbeat is abnormal. An abnormal heartbeat is 
referred to as an arrhythmia. There are many causes of arrhythmias, and they usually indicate 
that the heart is not functioning properly. The most common causes of out-of-hospital cardiac 
arrest are arrhythmias, specifically, ventricular tachycardia and ventricular fibrillation. If 
ventricular fibrillation goes undetected, and untreated the arrhythmia is usually fatal[22]. In the 
medical field monitoring heart rate is critical for patient care. There are many practices utilized 
for monitoring heart rate, as technology advances these devices have become increasingly more 




2.2.1.1 Manual Heart Rate Measurement.   
There are several techniques that exist for monitoring the heart rate, the most traditional is 
manually counting the beats at an artery that is close to the surface. The most common arteries 
that are used for this technique are the radial artery located at the wrist, and the carotid artery on 
the neck. The manual method requires placing two fingers on either artery and counting the 
number of pulses that occur in over 15 seconds, then multiplying this number by 4 to get the 
number of beats per minute(bpm). A healthy adult normally has a resting heart rate between 
60bpm to 100bpm[14].  
 
Figure 2.7: Visual descriptions of the manual heart rate measurement method on the carotid artery (left) and the radial artery 
(right). Image reproduced from [23]. 
 
 
2.2.1.2 Digital Heart Rate Sensors. 
The common method for measuring heart rate is digital heart rate sensors. Before the invention 
of pulse oximeters digital heart rate monitors were known as electrocardiograms (EKG or ECG). 
An ECG detects electrical changes in the heart using electrodes attached to the skin[13].  The 
electrodes pick up electrical impulses created by the heart during the cardiac cycle and then 
amplify the signal on an electrocardiograph[13]. The ECGs utilize the electrical impulses from 
heart contractions to detect heart rate, via electrodes that attach to the skin. These electrodes 
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from an ECG can cause irritation to the skin or burns. The ECG monitoring systems require 
multiple electrodes to be attached to the chest, back and abdomen, requiring time and effort to 
attach. Due to the limitations of ECG, this system is less optimal than optical non-invasive heart 
rate monitors in accessibility[24].  
 
Instead of using electrical signals like the EKG, current pulse oximeters use optics: a less 
invasive technology to monitor the heart rate. The pulse oximeter device is usually applied to the 
finger and uses light perfusion across the tissue to measure heart rate. The pluses oximeters and 
other digital heart rate monitors use photoplethysmography(PPG) signals to interpret heart 
rate[23]. This method of monitoring heart rate is most commonly used today and can also be 
found in many commercially available technologies including watches and headphones. 
 
2.2.2 Clinical application of Blood Oxygen Monitoring 
As discussed in the previous chapter the blood oxygen saturation (SO2) is a crucial vital sign 
that, when low, can indicate that oxygen is not readily being transported throughout the body. 
The brain is considered the most sensitive organ, if hypoxemia, or low SO2, occurs, the brain 
does not get enough oxygen, and visual, cognitive and electroencephalographic changes can 
occur[25]. There are many methods to measure SO2, or arterial blood oxygen saturation (SaO2), 
the percentage of bound oxygen in the arteries. Some methods utilize the transcutaneous tissue or 
peripheral blood to estimate the SaO2 by measuring the peripheral oxygen saturation (SpO2). 
SpO2 is often utilized for SO2 measurement because of its similarities to SaO2 and ease of 
measurement compared to arterial blood.  
 
Blood oxygen saturation characterizes how blood is being transported and reaching the tissues. 
In June of 2017 the BTS Guideline for Oxygen use in Adults in Healthcare and Emergency 
Settings indicated that healthy individuals between the ages of 18 to 81 should have an arterial 
blood oxygen saturation (SaO2) in the range of 94%-98%[26]. Throughout history there have 
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been many methods of measuring peripheral blood oxygen saturation (SpO2) values including 
chemical methods, electrical PO2 sensors, and other light attenuation oximeters.  
 
2.2.2.1 Van Slyke Method  
The Van Slyke Method is a means of measuring oxygen content using chemical reactions. The 
method requires a blood sample which is exposed to potassium ferricyanide which removes 
carbon dioxide from the sample. The sample is then compressed, and pressure is measured using 
a manometer[27]. After the CO2 is removed sodium hydrosulfite is introduced to the sample to 
remove the remaining oxygen[28]. Van Slyke Method utilizes the Van Slyke apparatus to 
manipulate the sample and measure the pressure after the chemical reactions. The apparatus 
pictured in figure 2.8 uses mercury and a stopcock control to operate the chemical reactions and 
pressure measurements[29].   
 
Figure 2.8: The Van Slyke apparatus contains a stopcock and mercury(Hg) to measure the chemical reaction and determine the 




2.2.2.2 Clark Electrode and Transcutaneous PO2 Sensors 
The Clark Electrode measures the partial pressure of oxygen PO2 using chemistry. Oxygen 
dissolved in an aqueous solution is exposed to 0.7V. A silver anode in a potassium chlorine bath 
will attract (Cl-) producing a constant flow of electrons, and a platinum electrode in the same 
bath reacts turning oxygen to hydroxyl ions (OH-). The number of electrons used in the platinum 
cathode is proportional to the PO2 value, thus the current across the electrodes corresponds to the 
PO2 in the solution[28]. Later the Clark electrode was modified to be used, in vivo, as catheter 
electrodes. There are many downsides to the Clark electrode including the need to draw blood 
and the invasiveness of the vivo electrodes. There are often problems making sure the tip of the 
electrodes stays clean and clear of any debris or congealed blood, and the most challenging 




Figure 2.9: Lenard Clark with his invention of defoaming in an oxygen bubbler that helped construct the Clark electrode. Image 
replicated from [30] 
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The Clark electrode can be placed on the outside of the skin to be utilized non-invasively. The 
transcutaneous partial pressure of oxygen (PtcO2) can be measured to indicate the arterial partial 
pressure of oxygen PaO2. The Clark electrode is heated on the skin, inducing hyperemia and 
increasing the blood flow to the affected area. The increased blood flow causes more O2 to be 
diffused across the skin more easily, causing the PtcO2 to approach PaO2[28]. Although the 
transcutaneous sensor is less invasive than then Clark electrodes it still has some disadvantages. 
The heating of the sensor takes approximately 10mins and has risks of burring, in infants it is 
suggested to be moved every 4 hours[28].  
 
2.2.2.3 Arterial Blood Gas Analyzer  
The arterial blood gas test measures the concentration of gases like oxygen and carbon dioxide in 
the blood. The arterial blood gas analyzer was developed by Dr.Severinghaus and his technician 
in 1958, using the technology involved in the Clark electrode. Dr.Severinghas modified the Clark 
electrode and combined his own research, measuring pCO2 and pH, into one analyzer to develop 
the arterial blood gas test[30]. The technology advanced throughout the years and by the 1960’s 
the device was universally available. The analyzer requires arterial blood, usually withdraw from 
the radial artery but in some cases, it is extracted from the brachial or femoral arteries. The 
extracted blood must be kept warm and tested within 30 minutes of taking the sample. Since the 
1960’s the device has advanced and can be utilized today to measure oxygen saturation in cases 
such as shock, hypothermia, or kidney failure where other non-invasive oxygen monitors are less 
accurate. Although the oxygen saturation data from an arterial blood gas test is extremely 
accurate, the test takes time, and because the blood oxygen saturation within the body can 
change instantaneously, the results from the test can be skewed. Because of the tests’s inability 
to perform instant measurements and requires a large blood gas analyzer, other non-invasive 
techniques have surpassed. 
 
2.2.3 Pulse Oximeters 
Pulse oximeters utilize light interaction to measure blood oxygen saturation and have become the 
most popular instrument to do so in medicine today. The first modern pulse oximeter was 
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developed in 1972 by Takuo Aoyagi and Muchio Kishi, who discovered the ratio of red to 
infrared light absorption through the tissue. After the discovery of the light ratio to measure 
oxygen concentration, and the tremendous advance in technology of that time, the pulse oximeter 
was constructed as an easy method for monitoring blood oxygen saturation. Monitoring real time 
oxygen saturation is critical to patient health, blood oxygen saturation can drop to critical limits 
within seconds. Pulse oximeters offer a convenient, non-invasive method for measuring blood 
oxygen saturation continuously[25]. 
 
 
Figure 2.10: Finger pulse oximeter, most commonly used in hospitals, the device is placed over the finger to read heart rate and 
blood oxygen saturation. 
 
Current on market pulse oximeters are small enough to be placed over the finger, as seen in 
figure 2.10. The instrument contains micro lights which interact with the peripheral blood flow, 
as the heart beats the lights detect changes in blood volume. Pulse oximeters are a compact easy 
to use device that measures blood oxygen saturation and heart rate. Pulse oximetry continues to 
be a critical component of standard of care monitoring for critically ill patients[31]. 
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2.3 Photoplethysmography  
Photoplethysmography(PPG) is an optical signal, produced by blood perfusion at the 
microvascular bed of the tissue[32].   PPG signals are utilized by wearable non-invasive devices 
known as pulse oximeters[33].  Pulse oximetry and PPG are often confused, but pulse oximetry 
is an application of photoplethysmography[15].  A photoplethysmograph is the waveform 
generated by blood volume changes from the pulse signal[34]. Changes in the blood volume are 
synchronous with the heartbeat, so the device can be used to calculate the heart rate[32].  
 
The PPG device utilizes light emitting diodes (LEDs) of different wavelengths and 
photodetectors, these components lead to the instruments small-scale and affordable 
characteristics[35].  Most PPG sensors are transmission-based, where the LEDs and the 
photodetector are located on opposite sides of the tissue. The relevant sensor in this thesis uses 
reflected-based PPG, where components are on adjacent sides. The LEDs beam light into the 
tissue where it interacts with biological material, and the light is either absorbed or scattered 
away. Scattered light can travel back to the sensor where the photodetector detects the light 
exciting the tissue[15]. 
 
A PPG signal can be obtained using two LEDs at different wavelengths, this signal is used to 
calculate peripheral oxygen saturation (SpO2). Each wavelength of light interacts with materials 
differently, thus the SpO2 can be calculated from the variation of the two LEDs’ interaction with 
the tissue.  
 
2.3.1 Photoplethysmograph Waveform 
During the cardiac cycle the heart contracts pushing blood throughout the body[13], [14]. When 
the heart contracts this is known as systole, during this phase the blood is forced out of the heart 
and into the arteries. The force of the blood moving out of the heart causes a buildup in pressure 
throughout the arteries and an increase in blood volume in the capillaries[15].  As the volume in 
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the tissue increases the amount of light from the LED hitting the photodetector will decrease, 
thus causing the absorbance to increase.  When the heart is relaxed in diastole the opposite will 
occur, the blood volume at the tissues will subside and more light will be detected on the 
photodetector, less absorbance[15].  This is the basic concept of the photoplethysmography 
waveform.  
 
2.3.2 Theory of spectrophotometers 
Spectrophotometry is the basis for all oximetry and the theory behind the PPG signal[28]. The 
spectrophotometer measures the absorption of light through a substance at a particular 
wavelength[28]. Spectrophotometers use a photodetector to measure the intensity of light that 
has passed through the substance.  
 
 
Figure 2.11: A spectrophotometer is comprised of a white light source which passes through monochromator scattering the light 
into all wavelengths, the spectrum of light then passes through an adjustable aperture to narrow the field of view. The light is 
then projected into the sample of interest, on the opposite side of the sample is a photoresist and an amplifier. Once the light hits 
the sample some is absorbed and some if reflected the reflected light is detected by the photoresistor amplified and displayed. 
 28 
 
The transmission (T), the amount of light passing through the material, is a dimensionless 
quantity that can be calculated using equation 2.1 by dividing the intensity of incident light (I0) 
by the intensity of light transmitted through the material (I). 
𝑇 = !
!!
        Equation2.1 
The absorbance (A), the amount of light absorbed by the material can also be calculated using 
the intensities of light before and after passing through a material: 
𝐴 = 𝑙𝑜𝑔 !!
!
       Equation 2.2 
Beer’s Law, which is derived from the absorbance and transmission equations, is utilized to 
calculate characteristics about the material light is passing through.   
 
 
Beer’s Law is as follows:  
 𝐴 = 𝜀(𝜆)𝑐𝑑       Equation 2.3 
 
Where 𝜀(𝜆) is the extinction coefficient of the substance at a given wavelength 𝜆 , c is the 
concentration of a substance and d is the path length the light travels through that substance[28].  
Beer’s Law is the fundamental governing equation for spectrophotometry and PPG sensors, as it 
provides a mechanism to calculate the concentration of a material.  Spectrophotometry is the 
technique utilized in PPG sensors to calculate the concentration of oxygen in the blood. In the 




2.3.3 Photoplethysmogram Correlation to Heart Rate 
Although there are many devices to measure heart rate, such as ECG monitoring systems, PPG 
sensors are considered low cost, portable, non-invasive and applicable in various 
environments[36]. The PPG sensors are also capable of monitoring for heart rate variations to 
predict cardiac issues or abnormalities[36]. The PPG sensor can detect the pulsatile signal of 
blood volume changes due to the heart rate (HR) via the photodetectors modulation from the 
original light signal[24].  The attenuation of light energy is dependent on the transmission or 
reflection of light in the bloodstream, and correlates to systole and diastole in the cardiac 




Figure 2.12: Photoplethysmogram where the amplitude correlates to the absorbance of light. The absorbance is related to the 
beating of the heart, when the hearts is in systole the absorbance is high and in diastole the absorbance is low.  Image 
reproduced from [24] 
 
From figure 2.12, illustrating the PPG waveform, the time interval between the systole pulses in 





     Equation 2.4 
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∑ 𝑁𝑁[𝑘]-∈[0$,0%]    Equation 2.5 
 
Where 𝑄## is the number of samples of normal intervals 𝑁𝑁 over time interval [𝑇" , 𝑇3].  
 
The PPG signal can use the pulses from the increased blood volume to calculate the heart rate. 
Most pulse oximeters or PPG devices today display not only SO2, but also heart rate, because of 
its critical correlation to body health.  
 
2.3.4 Acquisition of Photoplethysmography Signal  
Light from the LED’s in a photoplethysmography sensor interacts with biological tissues. This 
interaction can be complex involving scattering, absorption and/or reflection[37].  The 
technology utilized for collecting and evaluating a PPG signal can vary across devices. It is 
important that PPG signal devices use correlating components and wavelengths that interact with 
blood.  
 
2.3.4.1 Measurement Modalities  
Transmission and reflection are the two most prevalent types of PPG sensors. Transmission 
based sensors (Figure 2.13 (a)) are designed such that the LEDs are located above the finger, and 
project light through the extremity. These sensors are constrained to a clip, placed on the earlobe 
or finger where light can pass through the tissue [32]. On the contrary reflection based PPG 
sensors (Figure 2.13 (b)) do not utilize light passing through tissue, and theoretically can be 
positioned at any skin surface [32]. For the means of this thesis, the constructed PPG sensor 
utilized a reflection-based design. 
 31 
 
Figure 2.13: Two types of PPG sensors (a)Transmission based where the light source and the light detection component are on 
opposite sides of biological tissue and (b)Reflection based where the light source and the light detection component are on the 
same side of biological tissues.  Image reproduced from [24] 
 
As light passes through the tissues it reacts with materials in the body, causing light to scatter in 
different directions. For both types of sensors there are advantages and disadvantages, a 
transmission-based sensor must have enough light entering the tissue to ensure the light interacts 
with the blood and passes through the extremity. Because light travels through an extremity in 
transmission-based sensors, the results can be skewed from external light, and why most 
transmission sensors are designed to fully enclose the extremity, blocking out all light. The 
transmission sensor is widely utilized on the medical market today, the “clip” design eliminates 
variations that are found in a reflective PPG sensor.  
 
Reflective PPG sensors detect scattered light that propagates back toward the light source, this 
allows for more compact and easier to use sensors. The reflective sensors can be used where 
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transmission sensors cannot, the sensors can be used virtually anywhere where vascular skin 
exists on the body, whereas the transmission-based sensors are limited to areas where light can 
attenuate through tissue i.e. earlobe, or finger[38]. The reflective based sensors do have some 
disadvantages including, movement of the tissue on the sensor, and pressure applied, both can 
cause variation in the PPG signal. Eliminating or decreasing the extent of the reflective sensor 
disadvantages could cause this sensor type to progress beyond transmission.  
 
2.3.5 Components of the Photoplethysmograph  
As light enters the tissue it is absorbed and reflected by all of the biological components in the 
tissue. The skin, bones and arterial/ venous blood are primary absorbers of light[28].  As the 
heart enters systole blood flows to the extremities and the incidence of light reaching the sensor 
is decreased, when the heart relaxes the blood volume in the extremities decreases and the light 
increases [37]. The PPG signal is formed from two components AC and DC [24].  The pulsatile 
signal produced from the PPG waveform is known at the AC component and can be seen in 
figure 2.14 superimposed on the DC component [39]. The DC component, or non-alternating 
component of the signal represents the constant components of the tissue like skin pigmentation 
and bone material. The AC component represents the blood volume changes from a heartbeat, 




Figure 2.14: PPG signal from electrical components, the AC signal is the pulsatile variation due to changes in blood flow and 
the DC component of the signal is stagnant from the absorption of other biological components.  Image reproduced from [23]. 
 
Within a single heartbeat the AC component is considered the maximum absorbance, and the DC 
as the minimum, therefore the AC and DC are the peak and baseline of the PPG waveform 
respectively[36].  In the past the variation in the AC and DC components generated a challenge 
for consistent detection of blood volume changes, but the use of two wavelengths of light and 
calculating a ratio of AC to DC signal components, the variation in the signal can be normalized 
for a reflective based PPG sensor[37].  Further analysis of the AD to DC ratio will be discussed 
in later chapters.  
 
2.4 Optical Components of Photoplethysmography  
Optics are the primary component in a PPG sensor, they are responsible for transmitting and 
detecting light through tissue. Blood in the vascular bed of the tissue contains oxyhemoglobin 
(HbO2) a red blood cell fully saturated with oxygen molecules, and deoxyhemoglobin (Hb) blood 
without oxygen. The LEDs in the PPG sensor interact with the HbO2 and Hb to determine the 
percentage of oxygen saturated blood. 
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2.4.1 Principles of Photoplethysmography Oxygen Saturation 
Peripheral oxygen saturation (SpO2) is an important biological reference characterizing oxygen 
content in the blood, and the ability to transport the oxygen throughout the body.  Oxygen 
saturation calculation shown in equation 2.6, expressed as a percent the concentration of 
oxygenated hemoglobin (HbO2) over the concentration of oxygenated hemoglobin plus 





× 100%    Equation 2.6 
 
Pulse oximeters use PPG signals to measure the blood oxygen saturation (SpO2), by using Beer’s 
Law to calculate the concentration of oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) in the 
blood. The sensor uses two distinct wavelengths of light which interact with HbO2 and Hb 
differently, in turn providing differentiation between the two concentrations. How various 
wavelengths of light interact with HbO2 and Hb can be seen in figure 2.15, across the wavelength 




Figure 2.15: Extinction coefficient, related to absorbance, vs wavelength of light, for oxygenated (HbO2) and deoxygenated (Hb) 
blood. The oxygenated and deoxygenated blood cross at two points throughout the light spectrum, these are indicated by red dots 
and are referred to as isosbestic points.  
 
A similar graph illustrating the absorbance of HbO2 and Hb for wavelengths in the 600-1000nm 
range can be seen in figure 2.16, where lower wavelengths of light (600-700nm) HbO2 
absorption is less than the absorption of Hb, and at higher wavelengths (850-1000nm) HbO2 
absorption is greater than Hb. The wavelengths between 600-700nm are in the red region of the 
spectrum, and the 850-1000nm wavelengths are in the non-visible infrared region. The variation 





Figure 2.16: Extinction coefficient, related to absorbance, vs wavelength from 600nm to 1000nm, for oxygenated (HbO2) and 
deoxygenated (Hb) blood. The isosbestic point is located at 800nm before this point Hb has a high extinction coefficient than 
HbO2 and after this point Hb has a lower extinction coefficient than HbO2. Image reproduced from [36] 
 
In pulse oximetry the most common wavelengths of light utilized are 660nm and 940nm, any 
wavelengths can be used as long as they fall on either side of the isosbestic point. Beer’s Law 
relates the concentration of a material to the absorption, using this concept the SpO2 can be 
calculated. The concentrations of HbO2 and Hb which make up the SpO2 equation can be 
calculated using Beer’s Law: 
 
𝐴 = 𝜀𝐿𝑐    Equation 2.7 
 
Absorbance is equal to the extinction coefficient (𝜀) times the path length of light (L) times the 
concentration of the material (c). Using two wavelengths of light a ratio of absorbances can be 







      Equation 2.8 
 
Where the ratio of light is equal to the absorbance of light at wavelength 1 (𝐴4+) over the 
absorbance at wavelength 2 (𝐴45). From figure 2.16 the absorbance at l1 (red) for oxygenated 
blood is less than the absorbance at l2, thus when the blood is highly oxygenated (SpO2=100%) 
the ratio (R) will be less than 1 (approximately 0.4). If the blood is not oxygenated (Hb) the 
absorbance at l1 is greater than the absorbance at l2 and the ratio will increase, a R=1 
corresponds to an SpO2 value of approximately 85%.    
 
2.4.2 Photoplethysmography Biologically Applied Absorbance Ratio  
The light penetration depth in the skin depends on the tissue’s absorption and scattering 
properties, also known as the extinction coefficient [32], [35].  Because absorption is dependent 
on the wavelength of light, the LED’s in a PPG sensor require a specific wavelength to penetrate 
deep enough and acquire blood oxygen information. A PPG sensor measures the concentration of 
HbO2 and Hb in the blood using specific wavelengths of light, so it is critical that the 
wavelengths penetrate through the tissue to reach the blood, and correlate to different HbO2 and 






Figure 2.17: Depth of penetration vs wavelength of light, the wavelength of light directly correlates to the depth of penetration 
into the tissue. The larger wavelengths of light penetrate deeper than the lower wavelengths.  
 
From figure 2.17 it can be noted that greater wavelengths of light penetrate through tissue to 
reach the layer of tissue containing blood. To collect PPG signals light penetrating the tissue 
must be of a wavelength capable of reaching the vascular tissue bed.  Fortunately, as discussed in 
the previous section, the wavelengths of light utilized in PPG sensors are 660nm (red) and 
940nm (infrared), two wavelengths capable of reaching the vascular bed containing blood.  
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2.4.3 Photoplethysmography Electrically Applied Absorbance Ratio  
As discussed in the previous section a PPG signal is divided into two components, the pulsatile, 
AC component, and the constant background, DC component, or the maximum and minimum of 
a single PPG waveform respectively. The two LEDs utilized in a PPG sensor have distinct AC 





Figure 2.18: Dual PPG signal where one signal is from light in the infrared wavelengths(IR) and the other from red wavelengths 
(R). The AC and DC components of each signal are defined, AC(---) and DC (––). 
 
Where there are two PPG waveforms one IR (infrared) and the other R (red), to calculate the 
ratio of absorbances the signal becomes: 
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𝑅 = (&%&' &%()⁄ )*
(&%&' &%()⁄ )+*
= (&( -(⁄ )*
(&( -(⁄ )+*
    Equation 2.9 
 
The ratio of the AC and DC components cancels the absorbance of other components in the 
tissue such as bone or skin, and the ratio of the red light over the infrared light is used to 
calculate the SpO2, discussed in later sections. 
 
2.4.4 Oxygen Saturation and Beer’s Law 
Using Beer’s Law and the ratio derived from the absorbance of light through the tissue the SpO2 
can be calculated.  
 





× 100%    Equation 2.10 
 
Where the SpO2 is equal to the concentration of HbO2 over the total hemoglobin concentration 









    Equation 2.11 
 
The SpO2 is represented as a concentration of the oxygenated hemoglobin (CO) and 
deoxygenated hemoglobin (CD) over the total concentration CT in the blood. Using Beer’s Law 




The Beer’s Law, equation 2.12, relates the concentration and extinction coefficient of a material 
at a specific wavelength to absorption of light.  
 
𝐴 = 𝜀𝐿𝑐     Equation 2.12  
 
Absorbance is equal to the extinction coefficient (𝜀) times the path length of light (L) times the 
concentration of the material (c). Beer’s law can be represented with respect to oxygenated and 
deoxygenated blood in the following equation 
 
𝐴. = 𝐴$ + 𝐴- = 𝜀.𝐶.𝐿 = 𝜀$𝐶$𝐿 + 𝜀-𝐶-𝐿    Equation 2.13 
 
Where the total absorbance (AT) is equal to the absorbance of HbO2 (AO) plus the absorbance of 
Hb (AD). Equation 2.13 can be expanded using equation 2.12, replacing the absorbances with 
extinction coefficients, concentrations and pathlengths. The path length of light is equivalent for 
Hb (D) and HbO2 (O) and therefore does not require differentiation within the equation and can 









      Equation 2.14 
Where extinction coefficient total 𝜀! is defined by the HbO2 and Hb extinction coefficient 
𝜀"	and 𝜀# respectively, the concentration of HbO2 and Hb, CO and CD and, the total 








)     Equation 2.15 
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Replacing CO and CT in equation 2.15 with SpO2 from equation 2.11, the extinction coefficient 
total becomes: 
 
𝜀. = 𝜀$𝑆𝑝𝑂! + 𝜀-(1 − 𝑆𝑝𝑂!)     Equation 2.16 
 
Blood oxygen saturation is represented by the total extinction coefficient, a known value 
determined by the material and wavelength of light utilized.  
 








    Equation 2.17 
 
Where the ratio of absorbances is directly proportional to the ratio of extinction coefficients, and 
it was determined equation 2.16 that the total extinction coefficient is equal to 
 𝜀0 = 𝜀6𝑆𝑝𝑂5 + 𝜀7(1 − 𝑆𝑝𝑂5)     
Substituting the equation for the extinction coefficient total, equation 2.16, into the ratio of 






      Equation 2.18 
 




     Equation 2.19 
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The blood oxygen saturation (SpO2) is represented in terms of the ratio (R) of absorbances for 
the two wavelengths and the extinction coefficient of HbO2 oxygenated hemoglobin (𝜀") and Hb 
deoxygenated hemoglobin (𝜀#).  Where the extinction coefficients of oxygenated and 
deoxygenated hemoglobin are known values for the wavelengths utilized.   
 
The relationship between the measured absorbances of light and the calculated theoretical SpO2 
value can be plotted as a calibration curve figure 2.15, where the normalized ratio, R, represents 
the ratio of absorbances of red to infrared wavelengths of light.   
 
Figure 2.15: Oxygen saturation (SO2) versus the normalized ratio R, described in equation 2.17 as the ratio of absorbances of 
two wavelengths of light through blood. Image reconstructed from [40] 
 
The ratio of light absorbances to oxygen saturation is not a linear regression but is often 
represented as one because of the close correlation. Representing this correlation linearly yields 
the following linear equation: 
𝑆𝑝𝑂! = 110 − 25𝑅     Equation 2.20 
 
 44 
Where the oxygen saturation is equal to 110 minus 25 times the normalized ratio. R represents 




3.0 DESIGN OF REFLECTANCE BASED PHOTOTPLETHYSMOGRAPHY SENSOR  
This thesis investigates the design and development of a reflective based photoplethysmography 
(PPG) sensor. A custom-designed sensor was constructed to acquire PPG signals. A PPG sensor 
or pulse oximeter consists of two LEDs and one photosensor. The two LEDs of different 
wavelengths penetrate the tissue, once the light reaches the blood it is either absorbed or 
scattered. The scattered light signal is then detected by the photosensor and the light absorption 
can be determined. For this thesis the PPG sensor was designed to be utilized on the foot no 
greater than 13mm in diameter. The dual-wavelength PPG sensor is designed with a red 
wavelength LED and an IR wavelength LED  660nm and 940nm respectively. Because the 
sensor is restricted to 13mm in diameter, it is critical that the LEDs are powerful enough to 
penetrate through the tissue and small enough to fit within the sensor. The absorption, 
determined from the light detected by the photo sensor, from the two LEDs are used to calculate 
peripheral blood oxygen saturation SpO2.  It is important to utilize LEDs with a narrow 
wavelength range to eliminate variation in the SpO2 calculations, this is especially critical for the 
660nm LED, due to the steep slope of Hb in the extinction curve[28]. 
 
The absorbance of light, calculated from the PPG signal, is divided into AC and DC components, 
where the AC component is the pulsatile peak and the DC the steady valley. The 660nm and 
940nm LED both have an AC and DC component, and the amount of light absorption correlates 
to the SpO2. The desire is to optimize the 660nm and 940nm signal by increasing the distance 
between the peak and valley of the signals, or AC and DC components. The layout of the optical 
components within the sensor greatly impacts the outcome of the PPG signal. If the optical 
components are too close together the light will saturate the photodetector and the signal will not 
have any pulsatile data, and if the components are too far apart the light signal reflected off the 
tissue will not reach the sensor.  The distance between the LEDs and the photosensor directly 
relate to the signal to noise ratio of the PPG signal.  Optimizing the distance between the optical 
components improves the signal to noise ratio by increasing the AC to DC signal ratio.  
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The physical distance between optical components is not the only design characterizing to 
advance the PPG signal, electronics resistance is altered to reduce noise.  Depending on the 
sensor components the optimal resistance can be calculated and utilized to control the detected 
signal. Most pulse oximeters or PPG sensors contain photodiodes as the photosensor, but a 
phototransistor was selected due to its increased sensitivity[28].  A phototransistor operates 
varying current in response to light, this is then converted to a voltage signal.  
 
Two dual-wavelength sensors were designed during the extent of this research, throughout the 
report I will refer to two PPG sensors as Sensor-1 and Sensor-2.  The major difference between 
the two sensors is the number of photodetectors, commonly referred to as a photosensor. The 
first design, Sensor-1, is designed with two photosensors, and the second design, Sensor-2, with 
a single photosensor.  Sensor-2, the final sensor design, was constructed due to failures that 
occurred in Sensor 1, which are discussed in more detail throughout the chapter. Sensor-2 is also 
a dual-wavelength PPG sensor, but only contains 1 photosensor.  
 
3.1 Photoplethysmography Sensor-1  
Sensor-1 is designed with two photosensors to simultaneously detect both wavelengths of light 
reflected light from the LEDs. Sensor-1 contained four optical components divided into visual 
light emission and detection and infrared light emission and detection. These 4 components were 
printed on a 10mm printed circuit board (PCB), with intention to connect to an external 
motherboard. The LEDs on the PPG sensor project light at wavelengths in the visual light 
spectrum(380nm-740nm) and the infrared light spectrum(700nm-1000nm), with photosensors 
capable of detecting the light reflected from those LEDs. In Sensor-1, two photosensors were 
utilized, one to detect the visual light emission and the other to detect the IR light emission.  This 
would provide two signals for both wavelengths of light, and optimal for calculating SpO2. 
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3.1.2 Optical Components of Sensor-1 
The PPG sensor or pulse oximeter is designed with optical components to emit and acquire light 
signals. The sensor contains light emitting diodes (LEDs) which emit light into the tissue, and 
two phototransistors which detect the reflection of light. The PPG Sensor-1 is a dual-wavelength 
sensor containing two LED’s of different wavelengths, one at 660nm and the other at 940nm. As 
the LEDs emit light into the tissue the phototransistors detect the specific wavelength of reflected 
light, which is converted into absorbance. The sensor is designed with two phototransistors, one 
capable of detecting wavelengths of visible light and the other capable of detecting wavelengths 
of infrared (IR) light.  Because the ratio of absorbances is calculated from two pulsatile signals, it 
is critical that the reflected light is detected as separate signals. If the PPG sensor had one 
phototransistor capable of detecting both visible and IR light the result would be one signal 
contains of both wavelengths of light seen in figure 3.1. The two photosensors allow the device 
to detect both LED signals simultaneously. On the contrary a sensor with a single phototransistor 
is designed to switch the LEDs on and off to accommodate for the sensor’s inability to 
distinguish between IR and RED wavelengths.  
 
Figure 3.1: (A) two photosensors capable of detecting light from two different LED wavelengths, resulting in two separate 
absorbance signals. (B) one photosensor that detects both light wavelengths resulting in one signal comprised of both 
wavelengths.  
The optical components utilized in Sensor-1 can be divided into visual light acquisition and 
infrared light acquisition. For visual light acquisition, Sensor-1 consists of a red LED and an 
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ambient light sensor. The red LED (AP2012HD, Kingbright©, USA) has a peak wavelength at 
660nm shows in figure 3.2, and the ambient light sensor (ALS-PT19-315C/L177/TR8, Everlight 
Electronics Co Ltd., Taiwan) utilized can detect reflected emissions from the red LED. The 
spectrum for the ambient light sensor, a phototransistor, can be seen in figure 3.3, having a peak 
absorbance at 630nm and a sensitivity range from 390nm to 700nm. It is important to note that 
the ambient light phototransistor has a sensitivity maximum of 700nm, indicating that the 
photosensor will not be able to detect wavelengths of light greater than 700nm. Comparing the 
emission and detection spectrums for the red LED and the ambient light sensor, figure 3.2 and 
figure 3.3 respectively, it can be concluded the ambient light sensor will detect the 660nm signal 
emitted from the LED.  
 
 
Figure 3.2: Optical emission graph of the red LED in Sensor-1, (AP2012HD, Kingbright©, USA) labeled is red. Relative 




Figure 3.3: Absorption graph of the ambient light sensor utilized in Sensor-1, (ALS-PT19-315C/L177/TR8, Everlight Electronics 
Co Ltd., Taiwan). On the y-axis is relative sensitivity and on the x-axis is wavelength of light. The ambient light sensor has a 
peak sensitivity at 640nm.  
 
Sensor-1’s infrared (IR) light acquisition consists of an IR LED and an IR phototransistor. The 
IR LED (APT1608F3C, Kingbright©, USA) has a peak wavelength at 940nm illustrated in 
figure 3.4. The IR phototransistor (PT15-21B/TR8, Everlight Electronics Co Ltd., Taiwan) is a 
light sensor capable of detecting light emissions in the IR wavelengths. The IR phototransistor 
has a peak detection wavelength of 940nm and a range from 730 to 1100nm figure 3.5, 






Figure 3.4: Optical emission graph of the infrared LED in Sensor-1,  (APT1608F3C, Kingbright©, USA), with relative intensity 
on the y-axis and wavelength on the x-axis The infrared LED has a peek emission at 940nm. 
 
 
Figure 3.5: Absorption graph of the infrared light sensor utilized in Sensor-1, (PT15-21B/TR8, Everlight Electronics Co Ltd., 
Taiwan), with relative sensitivity on the y-axis and wavelength on the x-axis. The infrared light sensor has a peak sensitivity at 
940nm.  
 
The specs, including dimensions and operating conditions for the LEDs and photosensors can be 
seen in table 3.1 and 3.2 respectively.  
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Table 3.1: Optical specifications for red 660nm LED and IR 940nm LED  
Parameter  Red (660nm) LED  IR (940nm) LED 
Dimensions  2.0 mm x 1.2 mm x 1.1 mm 1.6 mm x 0.8 mm x 0.75 mm 
Peak Wavelength  (IF=20mA) 660 nm 940 nm 
Spectal Line Halfwidth (deltaY ½)  20 nm 50 nm 
Luminous Intensity  1.2 mcd - 
Forward Current   40 mA 20 mA 
Forward Voltage (IF=20mA) 1.85 V 1.2 V 
Capacitance 95 pF 90 pF 
Power Dissipation 100 mW 90 mW 
Reverse Voltage  5 V 5 V 




Table 3.2: Optical specifications for visual photosensor and IR photosensor  
Parameter  Visual Photosensor IR Photosensor 
Type Phototransistor Phototransistor 
Dimensions 1.7 mm x 0.8 mm x 0.6 mm 3.2 mm x 1.5 mm x 1.1 mm (1206) 
Peak Wavelength Absorbance 630nm 940nm 
Sensitivity Wavelength range  390nm – 700nm 730-1100nm 
Half angle - - 
Emitter-collector-voltage Voltage range 2.5V to 5.5V 5 V 
Collector-emitter voltage  - 30 V 
Collector Current - 20mA 
Dark Current  100nA 100nA 
Rise and Fall Time   0.11 ms – 0.22 ms - 
Power Rating  75mW 75mW 
Operating Temperature -40ºC – +85ºC -25ºC – +85º C 
 
Sensor-1 is designed with visual and infrared light subdivisions, each subdivision contains an 
LED and a phototransistor. The visual light and infrared subdivisions contain the LED: red 
660nm and IR 940nm, respectively. The visual light phototransistor has a detection range of 
390nm – 700nm, allowing the photosensor to detect the emissions from the 660nm red LED but 
not the 940nm IR LED. In contrast the infrared phototransistor has a range of 730nm – 1100nm, 
facilitating the detection of the 940nm IR LED but not the 660nm red LED. The emission 
intensity and the detection intensity of the LEDs and the phototransistors can be seen overlain 
with respect to wavelength in figure 3.6. The visual light sensor detects the emissions from the 
red LED but does not detect any emissions from the IR LED, and the IR light sensor detects 
emission from the IR LED, but not the red LED. This is optimal for the data acquisition of the 




Figure 3.6: Absorbance and emission spectrum of the optical components utilized in Sensor-1, The visual light sensor is 
indicated by the thick navy blue line, the red LED, the thin red line, the IR sensor the thick gray line and the IR LED, by the thin 
dark red line. The graph illustrates the IR LED emissions are detected by the IR sensor, and the red LED emissions are detected 
by the visual light sensor. 
 
3.1.3 Electronic Development of Sensor-1 
Sensor-1 electronics are implemented within a printed circuit board (PCB), containing through-
holes and padding shown in figure 3.7. The padding is designed with specific dimensions to 
allow the soldering of the SMD (surface mount device) LEDs and photosensors. The through-
holes in the PBC are implemented to solder wires through the sensor and control the device 
























optical parts with the appropriate connections. Not pictured, is the back side of the PCB, which 
contains the resistors needed to operate the sensors and LEDs. The back of Sensor-1 is designed 
with similar padding to solder the resistors needed to operate the sensor.  
 
Figure 3.7: 3D -rendering of sensor-1 PBC, there are 4 optical components, two sensors and two LEDs, labeled on the board. 
There are 4 pin- out holes in the board to wire each component.  
 
The electronic schematic for Sensor-1 can be seen in figure 3.8, as mentioned above the back of 
the PCB is designed with padding to accommodate the resistors, illustrated in the schematic 
below.  The sensor is designed to receive 5 volts of power, which is altered depending on 
component requirements. The red LED and IR LED have a forward voltage 1.85V (at 40mA 
forward current), and 1.40V (at 20mA forward current) respectively. Both LEDs require a 
resistor to supply optimal voltage to the components, a 820ohm resistor is implemented between 
the 5v and the LED leads. The phototransistor detection signal was optimized for both the visual 
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and IR photosensors, a 10kOhm resistor was added between the provided power and the 
photosensor.  
 
The visual and IR photosensors are phototransistors, operate by changing current in response to 
changes in light. The electronics involved with a phototransistor will be discussed in future 
chapters, but it is important to note that a voltage divider is needed to acquire voltage signal 
changes from a phototransistor. A voltage divider is implemented for both phototransistors with 
a 10kOhm resistor utilized, seen in figure 3.8  
 
 
Figure 3.8: Schematic of electronics for sensor 1. D1 and D2 are the Red and IR LEDs respectively, both LEDs require an 
820ohm resistor, R1 and R2. The phototransistors Q1(visible phototransistor) and Q2(IR phototransistor) require a 10kohm 




3.1.4 Failures and Limitations of Sensor-1 
Sensor-1 was connected to an oscilloscope to evaluate and optimize the signal.  Throughout the 
oscilloscope testing it was discovered that the visual light sensor (ALS-PT19-315C/L177/TR8, 
Everlight Electronics Co Ltd., Taiwan) was able to detect not only the red 660nm LED but also 
the 940nm IR LED. The visual light sensor did specify that it had a range of 390nm-700nm and 
would not be able to detect light greater than 700nm. Because the visual light sensor can detect 
the IR (940nm) emission the sensor is unable to successfully differentiate between the emitted IR 
signal and the red signal. Although it is optimal to have two separate photosensors capable of 
detecting contrasting wavelength spectrums, it was difficult to find a photosensor with such a 
limited detection range capable of fitting on a 10mm PCB. After evaluation of Sensor-1 design 
and components it was determined the best method is to reconstruct the sensor utilizing smaller 
electronic components and a single photosensor. It was decided to utilize the current ambient 
light sensor as the sole phototransistor in the design of Sensor-2, because it was able to detect 
both the IR 940nm and 660nm LEDs being utilized.  With only one photosensor the new sensor 
would have to utilize a sample and hold signaling technique to acquire signal from both LEDs. 
The sample and hold signaling technique allows the sensor to quickly alternate between 
collection of red and IR LED emissions and storing the data to generate a fluid emission graph.  
When using the switch and hold signaling it is important to note the frequency of rise and fall 
time of the phototransistor, as well as the rate of emission of the LEDs.  
 
Further testing of Sensor-1 identified that the visual light sensor actually acquired a higher-
quality signal from the IR LED emission than the red LED emission. The red emission was noisy 
and low because the LED was not as bright as the IR(940nm) LED.  Re-evaluating the LEDs 
utilized in Sensor-1, it was determined that the IR LED has a greater luminosity than the red 
LED.  For Sensor-2 a higher luminosity red LED with the same wavelength was utilized to 
provide more light penetrating the tissue and returning to the sensor.  
 
Even though it was decided that the IR photosensor would not be utilized in Sensor-2 it was 
discovered, when the IR LED and the IR photosensor were enabled the PPG signal exhibited 
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high amplitude, and high noise. The noisy signal from the IR phototransistor, was most likely a 
result of the component distance. When designing a reflective biased PPG sensor, the distance 
between the photosensor and the LED is critical to the acquired PPG signal. If the sensor and the 
LED are too close the light emitting from the LED will be directly absorbed by the photosensor 
before reaching the tissue, and the photosensor will be over saturated. If the LED is too far from 
the photosensor there will not be enough reflected signal from the LED to reach the photosensor, 
resulting in a low intensity noisy signal. The goal is to determine the optimal distance between 
the photosensor and the LED to optimize and refine the PPG signal. 
 
3.2 Photoplethysmography Sensor-2 
The PPG sensor or pulse oximeter is designed with optical components to emit and acquire light 
signals reflected from the tissue. The PPG sensor developed is a dual-wavelength sensor 
containing two LED’s of different wavelengths. As the LEDs emit light into the tissue the 
phototransistor detects the reflected light, which is converted into absorbance.  Sensor-2, the 
final sensor design, contains three optical components, two LEDs, with emissions in the visual 
and IR light spectrum, and one photosensor. The photosensor utilized is a phototransistor, which 
fluctuates current in response to changes in light. Most pulse oximeters or PPG sensors contain 
photodiodes as the photosensor, but a phototransistor was selected due to its increased 
sensitivity[28].  Sensor-2 components are implemented on a 10 3/8 mm dimeter circle printed 
circuit board (PCB). The sensor components are controlled using an NI myDAQ with compatible 
LabVIEW software. The software is capable of powering the LED’s, collecting the signal from 
the phototransistor and evaluating the signal to calculate and produce an SpO2 value.  Emissions 
from the LEDs enter the tissue, respond to blood volume changes and backscatter to be detected 
by the phototransistor. Once the reflected light is detected by the phototransistor, the response is 
converted from current to voltage and collected into the mDAQ for further signal manipulation.  
 
3.2.1 Optical components of Sensor-2 
 Similar to Sensor-1, Sensor-2 contains a red and IR LED, with emission at 660nm and 940nm, 
respectively.  Sensor- 2 contains a signal photosensor, the visual light sensor from Sensor-1 is 
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utilized in Sensor-2, due to the ability to detect both the IR and red LED emissions.  The 
schematic of the Sensor-2 can be seen in figure 3.9, including the two LEDs, and the visual light 
phototransistor.  The system consists of optical, electrical and signal processing components, all 
of which are designed together to generate a PPG signal and determine the SpO2.  
 
Figure 3.9: Sensor-2 circuit board schematic, there are 6 pin-out connections from the board, pin-1 is power to the IR LED, pin-
2 is power to the red LED, pin-3 is ground, pin-4 is power to the phototransistor, pin-5 is acquisition from the phototransistor 
and pin-6 is open.  
 
The 660nm red LED (SML-LX0603SRW-TR, Lumex Opto/Components Inc., USA) selected for 
Sensor-2 has a peak wavelength at 660nm and a 0805 surface mounting package (1.6 mm x 0.8 
mm x 0.60 mm). The 940nm IR LED (APT1608F3C, Kingbright, Taiwan) selected for Sensor-2 
has a peak wavelength at 940nm and a range of 50nm. The specifications for the IR and red 





Figure 3.10:  Emission spectrum of the red and IR LED respectively, with relative sensitivity on the y-axis and wavelength on the 




Table 3.3: Optical and electrical characteristics of the red (SML-LX0603SRW-TR) 660nm LED and the IR (APT1608F3C) 
940nm LED respectively 
Parameter  Red LED IR LED 
Dimensions  1.6 mm x 0.8 mm x 0.6 mm 1.6 mm x 0.8 mm x 0.75 mm 
Peak Wavelength  (IF=20mA) 660 nm 940 nm 
Spectal Line Halfwidth (deltaY ½)  - 50 nm 
Luminous Intensity  15 mcd - 
Forward Current   40 mA 20 mA 
Forward Voltage (IF=20mA) 1.7 V 1.2 V 
Capacitance  90 pF 
Power Dissipation 50 mW 90 mW 
Reverse Voltage  5 V 5 V 
Operating Temperature -40 to +85 ºC -40 to +85 ºC 
 
The phototransistor in Sensor-2 detects light reflected from the tissues and in response the 
current traveling across the component changes. The PPG sensor contains the surface mount 
ambient light sensor (ALS-PT19-315C/L177/TR8, Everlight Electronics Co Ltd., Taiwan) 
utilized in Sensor-1, capable of sensing a wide range of emissions.  The spectral range for the 
phototransistor is unknown but, discovered from failures in Sensor-1, is capable of detecting 




Table 3.4: Optical and electrical characteristics of the (ALS-PT19-315C/L177/TR8) phototransistor 
Parameter  Phototransistor  
Peak Wavelength 630 nm 
Sensitivity Wavelength range  - 
Half angle 390nm - ~1100nm 
Emitter-Collecter- voltage  2.5 V – 5.5 V 
Dark Current  100 nA  
Rise and Fall Time   0.11 ms – 0.22 ms 
Saturation Output Voltage 4.5 V 
Power Rating  75mW 
Reverse Voltage  5 V 
Operating Temperature -40ºC to +85 ºC 
  
 
3.2.2 Electrical Development of Sensor-2 
The PPG sensor is an optoelectronic sensor containing a dual wavelength light emission, a 
photodetector and a microprocessor system (MS). The PPG sensor developed in this thesis 
utilizes a National instruments myDAQ and LabVIEW as the microprocessor system. The 
optical components are mounted onto a custom printed circuit board (PCB) no greater than 
11mm in diameter.  Within the 11mm maximum diameter the board contains two LED’s and a 
phototransistor, which are separated to an optimal distance. The design of the PCB and the 
orientation of the components is crucial to the PPG signal.  In reflective-based PPG sensors the 
distance between the LED’s and the photosensor must be optimized to ensure the most accurate 
data is collected. The absorbance of the light will change as the distance between the optical 
components changes. The distance should be such that the maximum(AC) and minimum(DC) 
components of the PPG signal can be differentiated[28]. If the LEDs are too close to the 
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phototransistor, light from the LED will be detected by the phototransistor before reaching the 
tissues, thus producing a PPG signal with no information about the blood volume and high 
background noise. The background noise is known as the DC component of the PPG signal, or 
the valley produced by the heartbeat as seen in figure 2.18.  When the DC amplitude is greater 
than the AC amplitude (peak) noise will saturate the signal and the AC signal will be 
indistinguishable. A study was done by Mendelson and Ochs, investigating the optimal 
separation distance between the components and the results are shown in figure 3.11 [40].  
 
 
Figure 3.11: The separation distance of the photosensor relative to the LEDs on a PPG sensor with respect the AC (○)  and DC 
(□) components of the PPG signal. The y-axis represents the amount of reflected AC and DC signal as a voltage from a 
photosensor. The distance between the light sensor and the LEDs should be no less than 4mm and no greater than 11mm. Image 
recreated from [38]. 
 
Figure 3.11 indicates that if the LED and photosensor are 12mm apart the amplitude of the AC 
and DC component is low, and no light is reaching the phototransistor. As the separation 
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distance between the components decreases the AC amplitude increases and becomes 
distinguishable from the DC component.  The graph also illustrates, the DC intensity increases 
over the AC component as the separation distance is minimized, indicating saturation of the 
phototransistor. The study suggests a minimum of 4mm and a maximum of 11mm separation 
distance between the optical components is capable of increasing the PPG amplification two-
fold[38].  
 
A printed circuit board (PCB) contains of copper-based layers between non-conductive 
materials, the model supports electronic components and connections made through etching track 
or pads in the PCB. Altium Designer (Altium Ltd, Australia) was utilized to design and construct 
the PCB. After the PCBs were designed the boards were ordered through OSHPARK (Oshpark 
LLC, United States), a PBC board manufacturer. Figure 3.12 contains two CAD images, (A) and 
(B), illustrating the front and the back of Sensor-2’s PCB design, respectively. The front of the 
PCB (figure 3.12-A) contains four padding sites on the right and two padding sites on the left. 
The right padding sites are for the IR and red LEDs and the left is for the photosensor. The back 
of the PCB (figure 3.12-B) contains six padding locations, implemented for the addition of a 
SMD conn Header (TSM-103-01-T-DV-TR, Samtec ©) seen in figure 3.13.  
 
 
Figure 3.12: Printed Circuit Board layout for Sensor-2. (A) the top/front of the board indicating the soldering pads for the LEDs 




Figure 3.13: The SMD 6position conn Header (TSM-103-01-T-DV-TR, Samtec ©) soldered to the back of sensor-2 PCB. 
A computer-aided design (CAD) model of Sensor-2 can be seen in figure 3.14, containing the 
phototransistor and both the IR and red LED. The model was designed in SolidWorks to 
visualize the size and dimensions of the final sensor. The LEDs are approximately 4mm from the 
phototransistor, the maximum distance attainable within the 11mm diameter board. As discussed 
previously the distance between the photosensor and the LEDs is critical to the PPG signal 
obtained.  Anything less than 4mm would saturate the photosensor, so it was optimal to use the 




Figure 3.14: 3D rendering of Sensor-2 housing the optical components, the two LEDs are located on the right side of the sensor 
and the phototransistor on the left. The red LED is red, the IR LED is black, and the phototransistor is gray. The phototransistor 
is located 4mm to the left of the LEDs, the maximum distance that the 11mm diameter sensor could accommodate.  
 
The final sensor with the soldered optical parts is seen in figure 3.15, the phototransistor is 
soldered to the padding on the left and the LEDs on the right. The distance between the two 




Figure 3.15: Visual image of the front of the final sensor design (Sensor-2) with optical components soldered on, the two LEDs 
are located on the right side of the board 4mm away from the phototransistor which is located on the left. The LEDs are labeled 
on the board with “IR” and “RED” correlating to the IR LED and the red LED respectively.  
 
Sensor-2 electronic connection schematic, depicted in figure 3.16, houses 6 pins connected from 
the back of the PCB to terminals to control the components. The six pins consist of power to 
both of the LEDs, power to the phototransistor, signal out from the phototransistor and ground. 






Figure 3.16: Pin layout for the control of Sensor-2, with two pins for power to the IR and red LEDs, labeled “IR” and “RED” in 
the schematic, one pin for ground labeled “GRND”, and an in and out pin for the phototransistor labeled “PT IN” and “PT 
OUT”  
 
Figure 3.17 is the circuit diagram for the two LEDs, 3v supplied from the NI MyDAQ passes 
through a 2.2kW resistor before passing through the LED and connecting to ground. This 
schematic is the same for the IR (940nm) and red (660nm) LEDs.  
  
Figure 3.17: Electronic schematic for the LEDs on the PPG sensor, the red LED labeled “RED LED” is supplied +3v from port-
1 on the myDAQ which travels through a 2.2kOhm resistor before powering the LED. The IR LED labeled “IR LED” is similarly 
supplied +3v that passes through a 2.2kOhm resistor, form port-2 on the myDAQ. Both LEDs are then connected to a similar 
ground port.  
 
Sensor-2 utilizes a phototransistor as the photosensor, as mentioned above the phototransistor 
changes current in response to light. Because of this a voltage divider is needed to receive a 
voltage signal from the phototransistor. The schematic for this component can be seen in figure 
3.18 where 5v is supplied to the phototransistor. The 5v passed through the phototransistor, to a 
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10kW resistor and then connecting to ground to close the circuit. The phototransistor output 
signal is measured between the phototransistor and the 10kW resistor. 
 
Figure 3.18: Phototransistor electronic schematic +5v is supplied to the phototransistor from the myDAQ 5v pin, the PT is 
powered and connected to ground via a 10kW resistor. The out signal from the phototransistor is collected between the 
phototransistor and the 10kW resistor. The signal is acquired on the myDAQ via the analog input +1/-1. 
 
The phototransistor circuit operates using the voltage divider, when there is minimal light hitting 
the phototransistor, the voltage out signal will be low, as more light begins hitting the sensor the 
voltage out will increase toward Vcc in this case +5v form the NI nyDAQ. The voltage out signal 
will change as more or less light is hitting the sensor. Measuring the voltage out provides a signal 
in response to more or less light hitting the sensor, representing the increase and decrease in 
blood perfusion from the heart beating. 
 
3.2.3 Signal acquisition and Processing (LabVIEW) of Sensor-2 
The majority of signal processing is performed using National Instruments (NI) LabVIEW suite. 
The LabVIEW suite contains a powerful graphical block coding software and compatible 
external microcontrollers. The myDAQ, an external microcontroller in the LabVIEW suite, is 
utilized to control the components of Sensor-2. The myDAQ is responsible for powering the 
LEDs and the phototransistor, as well as receiving and analyzing the phototransistor signal. The 
LabVIEW software processes the signal and relays controls to the myDAQ. figure 3.19 
illustrates the signal flow from the sensor components to the LabVIEW software. One of the 
 69 
reasons LabVIEW is such a powerful software is because of its integrated graphical user 
interface (GUI). For Sensor-2, a GUI created in the LabVIEW software, relays signals to the NI 
myDAQ, which is connected to the sensor and controls the optical components (figure 3.19). 
 
Figure 3.19: The schematic diagram for the PPG sensor processor includes a National Instrument myDAQ which receives and 
feeds information to the LabVIEW GUI and software. The myDAQ not only powers the two LEDs and the phototransistor, but 
also acquires signal from the phototransistor.  
The majority of PPG sensors utilize an external motherboard that controls the components, but 
for the extent of this thesis it was optimal to utilize the LabVIEW suite to optimize the signal. In 
a PPG sensor signal processing is a critical component, the control of the LEDs, the signal 
transmitted to the phototransistor, the signal acquired from the phototransistor as well as the 




4.0 SIGNAL PROCESSING 
As blood volume changes due to the heart rate, more blood reaches the extremities and the 
phototransistor reacts to more or less light hitting the sensor. This signal can be manipulated to 
optimize the information. There are many signal manipulation processes utilized in PPG sensors, 
the majority are applied utilizing a variety of electronic components, and a microprocessor. In 
some sensors additional electronic components are designed to amplify, filter and sort the data 
appropriately before the signal is processed by an external microprocessor. Figure 4.1 is a 
general signal manipulation flow diagram for a PPG sensor, for each component in the schematic 
the signal is optimized for the ratio calculation.  The phototransistor signal is processed through 
an initial amplifier to reduce the signal to noise ratio (S/N). As discussed in previous chapters the 
phototransistor cannot differentiate between the red and IR LED signals, so a sample and hold 
mechanism is utilized to separate the signals. The sample-and-hold mechanism is triggered by 
the LED states, for example when the IR LED is on the sample-and-hold is collecting the IR 
signal, and vice versa. The separate components are individually processed through a filter, and 
the DC offset is determined. The separate signals are then amplified individually and compared 





Figure 4.1: General PPG signal manipulation, signal received from the Phototransistor enters an amplifier to increase the signal 
received, the signal is then manipulated using the sample and hold technique were the signal is divided into IR and Red signals. 
Both signals are filtered and normalized by evaluating the DC off-set, after normalization the AC component of the signals are 
amplified, the data is then collected, and the ratio is calculated.  
 
The majority of PPG sensors manipulate the signal via electronic components, for the sensor in 
this thesis all of the signal optimization and calculation is executed using the NI myDAQ and 
LabVIEW processing suite. The NI myDAQ and LabVIEW software are capable of controlling 
the PPG sensor components as well as manipulating the signal similar to electronic components.  
 
4.1 LabVIEW and My DAQ Component Control   
LabVIEWTM stands for Laboratory Virtual Instrument Engineering Workbench and is a system-
design platform for visual programing from National Instruments©. All of the necessary 
components for signal manipulation described in figure 4.1 are processed using LabVIEW. The 
NI package uses a myDAQTM an external data acquisition device to acquire signals. The 
myDAQTM is paired with the NI LabVIEWTM software, where the signals acquired from the 
myDAQTM are processed. The schematic in figure 4.2 describes the signal processing for the 





Figure 4.2: The LabVIEW Programing suite is responsible for relaying information the NI myDAQ which provides power to the 
LEDs and the phototransistor. Data from the phototransistor is acquired through the myDAQ and processed in the programing 
software. The signals and controls are processed and viewed through the LabVIEW GUI. 
 
The LabVIEW program encompasses all of the signal manipulation involved in a PPG sensor, 
the signal manipulation in figure 4.1 is indicated in figure 4.2 as LabVIEW software. Signal from 
the LabVIEW software is sent to the NI myDAQ where the signal is relayed to drive the LEDs 
and the phototransistor. The information received from the phototransistor is collected through 
the myDAQ and processed in the programing software and displayed through the programs 




4.1.1 NI myDAQ Sensor Component Control 
The NI myDAQ is a powerful signal acquisition device capable of a variety of electrical signal 
drivers and acquisitions. The myDAQ is equipped with analog signal acquisition input (+/- 10v), 
7 digital IO pins (0-5v), a common ground, and a 5v power supply. The DAQ also incorporates 
audio in and out as well as a digital multimeter.  
 
The NI myDAQ is utilized as the digital driver to control components and acquire the 
phototransistor signal. The electronic control of the PPG sensor via the myDAQ is illustrated in 
figure 4.3, the wire connections from the myDAQ to the sensor are connected to the front of the 
board, this is done to provide a more comprehensive understanding of the electrical components, 
but it is important to note that the PPG sensor is wired via pins on the back of the board. The 
PPG sensor seen in figure 4.3, consists of the IR LED (black), the red LED (red) and the 
phototransistor(grey), each element on the sensor is connected to the myDAQ. The myDAQ 
controls the red LED via the DIO port1 and, the IR LED via DIO port2, both LEDs require a 
2.2kW resistor to optimize the emission signal.  The phototransistor is supplied 5v of power from 
the myDAQ and then wired to ground to close the circuit.  Between the phototransistor and 
ground is a 10kW resistor, the signal is collected between the component and the resistor, 
depicted in figure 4.3. The myDAQ collects the phototransistor signal via the analog 1+ port, 





Figure 4.3:  NI myDAQ (the white box) wiring diagram to the PPG sensor, the figure shows wiring on the front of the sensor, this 
is for comprehension of the electronics in the actual sensor the connections are from the back. The red(red) and the IR 
LED(black)s are connected to pins 1 and 2 on the myDAQ DOI out pins. The myDAQ pins providing power to the LEDs pass 
through a 2.2kW resistor before powering the LEDS. The myDAQ 5v pin supplies power to the phototransistor, and the signal out 
from the phototransistor is collected by the AI pin 1+ on the myDAQ. The phototransistor out passes through a 10kW resistor 
before connecting with the LEDs and closing the circuit to ground. 
 
4.1.2 LabVIEW Software Component Control  
As discussed above the digital outputs (DIO pins) on the myDAQ are wired to the LEDs on the 
PPG sensor, and control power to the LEDs. The LabVIEW software controls the myDAQ and 
thus regulates the power supplied to the LEDs. The software is designed to drive the LEDs, 
similar to how a LED driver circuit would operate in stand-alone PPG sensors. The PPG sensor 
contains two LEDs and one phototransistor, and the phototransistor reacts to light from both the 
660nm LED and the 940nm LED, because of this a sample-and-hold technique is needed to 
collect signal from the LEDs nearly simultaneously. The sample-and-hold technique works when 




An example of the LabVIEW software components needed to drive the LEDs, is illustrated in 
figure 4.4, contains a series of local variable controls (A), timers (B) and DAQ controls (C). The 
local variable control, figure 4.4-(A), is utilized to send information indicating the state of the 
LEDs to other components of the LabVIEW software. The timers or wait controls, figure 4.4-
(B), are utilized to provide a pause in the sequence. The final component in the PPG sensor 
component control, figure 4.4-(C), is the myDAQ control, the signaling between the software 
and the myDAQ which provides power to the components and supplies the LEDs with power. 
The DAQ controls, the blue square in figure 4.4-(C), are wired a Boolean true or false, 
correlating to turning the LED on or off.   
 
Figure 4.4: Example of sequence components in the LabVIEW software to drive the LEDs via the myDAQ. (A)Variable controls 
which change the state of digital variables that represent the LEDs, this is utilized to relay information about the LED states to 
other aspects of the software. (B)A timing sequence to delay the time between software actions. And (C) the blue blocks are 
express Vis that relay information to the NI myDAQ and provide power to specific pins, the express Vis are controlled with true 
and false Boolean commands.  
 
The software to control the LEDs, utilizes a structure known as a sequence event, where each 
component in the sequence will operate in succession (figure 4.5). The sequence begins at left 
and moves from left to right through each segment in the sequence. If the sequence is placed in a 
while loop, once the sequence is completed it will go back to the first segment and start over. 
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Figure 4.5: An example of a sequence designed in the LabView software; the green box encompasses the full sequence structure 
which is divided into sequence sections outlined with the red box. The arrows are the beginning of the sequence structure 
represents the path of the processes, the software will complete the task in each section in sequence.  
 
Power to the LEDs is controlled by the LabVIEW program which relays signal to the DAQ and 
drives the LED states. The diagram above is an example of a sequence that can be utilized to 
control the LED states, and rapidly turn on and off the LEDs. 
 
4.2 LabVIEW Signal processing  
The LabVIEW software components needed to drive the LEDs was discussed above, the rapid 
switching of the LED states is used in the sample-and-hold technique. This technique is utilized 
so the phototransistor can collect emissions from the two LEDs, at virtually the same time. The 
myDAQ receives a signal from the LabVIEW software to control the components of the PPG 
sensor. The myDAQ also provides power to the phototransistor and acquires the returning signal 
from the phototransistor at the analog input. Data received from the phototransistor is 
manipulated in the LabVIEW software to optimize the signal. The received signal is processed 
through a sample and hold technique to separate the red and IR LED data collected by the 
phototransistor.  The signal is amplified and filtered to exhibit the signal components and 
calculate the heart rate as well as the SpO2.  
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4.2.1 Sample and Hold Technique 
The sample-and-hold technique is needed in the PPG sensor, because it is designed with two 
LEDs and one phototransistor, capable of detecting both wavelengths of light. The technique 
works by driving the LEDs to alternate states rapidly, when one LED is on the other is off. For 
example if the red 660nm LED is powered on the IR 940nm LED must be off, this allows the 
phototransistor to pick up light emissions from only one LED. The other processing components 
of the sample-and-hold technique involves the signal being received by the photoresistor. If the 
signal was not divided into two separate signals the phototransistor would detect rapid switching 
between the LEDs and nothing about the red or IR LED signal could be differentiated. The 
sample-and-hold technique collects the “sample” or data from the phototransistor when 
indicated, and “holds” that data, until indicated to collect more data. For example when the red 
LED is powered on, signal from the LED will reflect off the tissue and become detected by the 
phototransistor, the signal will then be transported to the myDAQ and LabVIEW software. The 
signal received will be flagged as a “red LED” signal, and stored to a “red LED” signal data 
location. The “red LED” flagging will then turn off as the IR LED on the PPG sensor turns on 
and the LabVIEW software flags the new incoming data as “IR LED”.  An example of the 




Figure 4.6: The sample and hold technique utilized for a PPG sensor with two LEDs and one photosensor, the first signal (signal 
1) is the phototransistor signal when the first LED is powered, and signal 2 is the signal from the phototransistor when the 
second LED is powered. The software relays which LED is powered so that the incoming signal from the phototransistor is 
categorized with the correct wavelength. The separate signals can then be stitched together on separate graphs as separate 
signals. 
 
If the sample and hold technique can be executed at a high enough frequency then the PPG 
signals can be stitched, meaning the missing data ignored and the data for each signal is 
connected to make a complete waveform instead of having gaps in the signal. Because the data is 
being stitched together and gaps ignored it is critical the sample and hold switching happens at a 
high rate. The calculation of SpO2 requires the AC (peak) and DC (valley) of the IR and red 
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signals at the same time point, utilizing the sample-and-hold technique and the stitching of 
signals supplies these data points, for both wavelengths. 
 
4.2.2 LabVIEW Software Signal processing 
The signal coming in for the phototransistor via the analog input +1 on the myDAQ, must be 
manipulated to separate out the IR and red signals and evaluate the HR and SpO2 values. Below 
figure 4.7 is the LabVIEW program designed to collect the PPG signals from the phototransistor 
and process the data. The first aspect of the program is the signal acquisition from the myDAQ 
indicated by figure 4.7-A, signal from the phototransistor is acquired by the myDAQ and 
processed in LabVIEW at a rate of 10kHz.  
 
The signal is then processed using a relay switch figure 4.7-B, the relay switch in LabVIEW is 
similar to a sample-and-hold circuit, where the signals will only be acquired while the relay is 
enabled. As discussed in the previous section the LED driver circuit local variable control 
component enables and disables the relay switch. For example, when the red LED is on the local 
variable control will signal the red-relay to turn on and the signal from the phototransistor will be 
collected, and vice versa for the IR LED.  
 
Once the signal for the IR and red LEDs are collected separately, there are passed through a 
bandpass filter in the LabVIEW software figure 4.7-C. The bandpass filter is a signal filtering 
control that is built into the software controls, the filtering is used to eliminate background noise 
and extract only the heart rate signal. A bandpass filter operates by extracting only the desired 
frequencies within the signal, defining a low pass frequency and a high pass frequency. A study 
was done to evaluate the optimal low pass filter (LPF) for calculating the AC/DC ratio of a PPG 
signal. The study indicated that lowering the frequency of the LPF resulted in a ratio with lower 
signal to noise and decreased standard deviations (SD)[34]. The bandpass filter utilized for the 
PPG sensor was set to 0.5Hz to 3Hz to extract only the frequency of signal needed.  
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After the signal is filtered the smoothed data is processed in an amplitude measurement 
component of the software, this component is continuously evaluating the amplitude between the 
positive peak and the negative peak. By measuring the peak-to-peak components of the PPG 
signal the ratio of AC/DC is extracted for both the IR and red signals. As discussed in previous 
sections the AC/DC ratio is what is utilized in the calculation of the SpO2 percent. The ratios are 
stored and collected for evaluation figure 4.7-E where the ratio of the IR signal will be divided 
by the ratio of the red signal, to get the final ratio to evaluate the blood oxygen percentage.  
 
Figure 4.7: LabView software signal manipulation and processing, starts with (A) the DAQ assistant express VI relays the 
incoming data from the phototransistor from the NI MyDAQ to the LabVIEW software (B) the data from the is split into two 
signals using LabVIEW express VI relays. The two signals are then collected and Filtered (C) the filter is a band pass filter with 













Figure 4.8 applies the same signal processing from 4.7 but the signal is acquired in a case 
structure to cycle through sensor states. The three states utilized in the case structure below are, 
“RED”, “IR” and “DARK”, each case is a different sensor state. This provides information about 
the background signal which is important for evaluation of the signal for example the 
background or “DARK” signal might be different if you are in a bright room or apply more 
pressure to the sensor. Figure 4.8 is divided into two sections A and B; figure 4.8-A controls the 
state and signal type being processed in section B.  Figure 4.8-A cycles through three states 
“DARK”, “RED” and “IR” for each state a different combo box (figure 4.8-B.1) is enabled. 
When figure 4.8-A is in the “DARK” state the combo box is in the “DARK” state and turns off 
both of the LEDs. When figure 4.8-A is in the “RED” state the combo box drives the red LED on 
and the IR LED off, and the “IR” state turns the IR LED on and the red LED off.  For each state, 
the correlating signal from the PPG sensor is collected, after collection the data is passed to a 
relay switch to collect the IR and red LED signal figure 4.8 – B.2. The peaks of the signal are 
determined and passed through the SpO2 equation (figure 4.8-B.3). The SpO2 equation was 
discussed in section 5.3, and is the linear correlation between the ratio of signals and the SpO2 




Figure 4.8: The PPG sensor signaling structure that controls the state of the LEDs and the collection of signal (A) the case 
structure responsible for controlling the state of the signal evaluation which cycles through dark, red and IR states. These states 
are relayed to the signal evaluation structure (B) where the incoming signal from the sensor is passed into the case structure 
(B.1).the case structure controls the LED states and collects the signal.  (B.2) processes the signals from the sensor and the last 
component (B.3) is the SpO2 evaluation. 
The ratio of signals is defined by the equation below: 
 
𝑅 = (%456 %478⁄ )9
(%456 %478⁄ ):9
= (%( #(⁄ )9
(%( #(⁄ ):9
    Equation 4.1 
 
Where the R is equal to the ratio of the red signal AC/DC over the IR signal AC/DC. The ratio is 
then implemented into the linear SpO2 equation (equation – 2.20) to calculate the blood oxygen 
percentage. The LabVIEW program is capable of implementing the calculated ratio into the 
SpO2 equation indicated in figure 4.8-B.3.  
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4.3 Virtual instrument Monitoring  
The LabVIEW contains the ability to develop a graphical user interface (GUI) to allow user 
interaction with the software. The PPG sensor is equipped with the LabVIEW GUI capable of 
displaying and calculating the data. The graph on the left in figure 4.9 displays the raw unfiltered 
data that is collected by the sensor, on the right of this graph is the signal after being processed 
through a 0.5-3Hz bandpass filter. The user can turn on the device by pressing the switch to 
pulse oximeter, once the pulse oximeter is turned on the user can watch the graphs as the signal 
is collected. The RED and IR green buttons indicated at the top of figure 4.9 will turn on and off 
indicating which signal is being collected. The heart rate and SpO2 value will be displayed in the 
box to the right. The user also has the ability to collect the data, after the user inputs the name 
and trial number as well as the path location, the blue button at the top of the GUI can be pressed 




Figure 4.9:  LabVIEW programing graphical user interface at the top of the GUI in brought blue is the collect button once this is 
pressed the program will collect the PPG signal data for 15 seconds. In this GUI you can enter the name and trial number as 
well as the location to store the results. On the left side of the GUI is the unfiltered raw data and on the right is the filtered data 





5.0 MECHANICAL SIGNAL OPTIMIZATION 
The goal of this thesis was to implement the PPG sensor into the cap of the Electronic Tuning 
fork (ETF). The ETF is placed on the bottom of a patient’s foot and vibrates to indicate 
neuropathy, or lack of feeling. The ETF is a hand-held rectangular instrument with a small cap 
located at the base of the device which comes in contact with the foot figure 5.1.  
 
Figure 5.1: Electronic Tuning Fork utilized in this thesis, the device is 12 inches long and fits in your hand. The device is used 
for measuring diabetic foot neuropathy and the cap (indicated in figure) is placed on the bottom of your foot.  
 
The PPG sensor for this thesis was logistically designed to fit in the cap of the ETF, to advance 
patient care by providing doctors with multiple biological vitals using a single device.  Figure 5.2 
illustrates the ETF cap dimensions, and the maximum usable area to build the PPG sensor. The 
sensor’s physical design was optimized to fit in the ETF cap and come in contact with the 




Figure 5.2: The cap from the ETF has a height of 15.95mm and an inner diameter of 12.6mm. The PPG sensor must fit within the 
cap, so the dimensions are critical to design.  
After development of a PPG sensor dimensionally compatible with the ETF cap and capable of 
calculating SpO2 the objective was to optimize the PPG signal from the sensor by altering the 
light attenuation using mechanical structures.  
 
A normal pulse oximeter utilizes transmission based signaling, eliminating factors that can 
negatively impact the signal in a reflective PPG sensor. The type of sensor and the 
implementation of the sensor in this thesis allows for variation of applied pressure and 
movement. Although reflective based sensors have variations in signal due to pressure changes 
and movement, they are more optimal due to reduced limitation of use. One study that compared 
the contact pressure of reflective pulse oximeters to accuracy of results, found that the increased 
pressure of a sensor applied to the forehead, 12 and 27 kPa, resulted in a decrease in error and 
improved measurement accuracy for both SpO2 and heart rate[41].  In contrast the study did 
determine that less applied pressure, 4kPa, caused both the SpO2 and heart rate results to 
decrease in accuracy, from insufficient contact and movement. Movement from the patient or 
doctor can allow more or less light to reach the sensor therefore interfering with the PPG signal 
received. The goal is to design an overlay on the surface of the PPG sensor PCB to optimize the 
signal. The overlay is capable of directing the light through the tissue to amplify the signal and 
reduce the signal to noise ratio, which compares the signal intensity to the background noise 
from a signal.  
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5.1 Signal to Noise Ratio 
The signal to noise ratio(SNR) is a critical metric of any signal. It calculates a value representing 
the amount of background noise in relation to the desired signal. Because of the PPG sensors 
variation from pressure and light perfusion the SNR is an important metric to indicate how the 
device is performing. The SNR formula is indicated by equation 5.1 
𝑆𝑁𝑅 = ;0(1)&2
<0(1)&2
       Equation 5.1 
Where µ is the average signal value and s the standard deviation of the signal. An example of a 
PPG signal with noise is illustrated in figure 5.3.  As the amplitude is changing over time, there 
are minimal variations in amplitude throughout the signal, which is the noise.  
 
Figure 5.3: Example of a PPG signal containing noise, where the small variations in amplitude represent noise in the signal and 
the larger changes in amplitude are the desired signal. 
 
The PPG signal fluctuates in amplitude, representing the pulsatile signal of blood perfusion. As 
discussed in previous sections the PPG signal has an AC and DC component, representing the 
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peak and valley respectively. Both components can have fluctuating SNR because they represent 




     Equation 5.2 
Where the SNR becomes the average AC signal minus the average DC signal over the standard 
deviation of AC minus DC, and the equation for the standard deviation becomes: 
 
𝜎&(/-( = 8𝜎&(! − 𝜎-(!    Equation 5.3 
 
Where the standard deviation of the signals is the sum of squares of the components.  
 
The SNR is an important component to optimize the PPG signal, the goal is to decrease the ratio 
having a high signal and low noise. The filtering discussed in the previous section will remove 
some of the noise from the PPG signal, but the signal can be further optimized by evaluating the 
SNR of the raw signal. As the various cap structures are utilized the SNR of the raw signal can 
be evaluated to determine how well the cap is optimizing the data.  
 
5.2 Structures 
Three caps were designed to fit over the PPG sensor and direct the LED and phototransistor 
different directions to optimize the PPG signal. The three designs can be seen in figure 5.4, 
where all caps were designed with a crevice in-between the LEDs and phototransistor intended to 
allow more tissue to fill between the optical components. The goal was to design the cap to 
maximize the amount of light from the LEDs to interact with the tissue and return to the 
phototransistor.  The first cap design, figure 5.4-A, is designed with the outlet for the LEDs and 
the inlet for the phototransistor directed straight up, this is the control design, the middle of the 
cap is carved out to maximize the tissue between the components. The second cap design, figure 
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5.4-B, has the outlets for the LEDs directed inwards and the phototransistor inlet directed 
inwards. The concept behind the second cap design is for more light reflected off the tissue to 
reach the phototransistor, hence both components directed toward the midline. The third and 
final cap design, figure 5.4-C, is constructed to direct the light and phototransistor away, the 
concept for this design is to allow the light to travel further into the tissue before returning to the 
phototransistor. The third design is constructed to reduce signal to noise ratio and eliminate light 
bleeding for the LEDs to the phototransistor before reaching blood components.  
 
 
Figure 5.4: Initial cap overlay designs, constructed to direct light and optimize PPG signal all constructed with the same 
dimensions as the (A) is designed to project light from the LEDs directly out  
 
The caps were designed using Solidworks© a CAD (computer-aided design) modeling software. 
After design the caps were printed using Ultimaker 2+TM  a 3D-printer capable of printing 
approximately 2.58mm. Due to the size and complexity of the caps constructed for the PPG 
sensor and the limitations of the 3D printer, the caps designed to direct light outward and inward, 
figure 5.4-B&C, could not be printed successfully. Although the cap design with the light 
attenuation directed straight, figure 5.4-A, was able to be printed the pulsatile signal was not 
detected when this cap was utilized on the sensor.   
 
The above cap designs were simplified to determine why there was no signal seen when using 
the first cap designs figure 5.4-A and if a similar cap could help determine the problem and 
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optimize the signal. Figure 5.5 shows the next stage of caps designs tested on the PPG sensor. 
The first is the PPG sensor contains a signal divider between the LEDs and the phototransistor, 
the second contains a full cap encompassing all the components, and the third is a sensor with no 
obstruction to the optical components. 
 
Figure 5.5: The two modified versions of the PPG sensor and the bare PPG sensor for testing. 
 
The final cap designs tested are illustrated in figure 5.5. All of the caps are constructed using 
Solidworks© and 3D-printed on the Ultimaker 2+TM  using black PLA material.   
 
The first design is the “Middle Divider”, figure 5.6, designed with a divider between the LEDs 
and the phototransistors on the PPG sensor. The divider design is constructed with intentions of 
eliminating light bleeding from the LEDs into the photosensor without first entering the tissues. 
The black middle divider will force the LED emission into the tissues, in turn causing the only 
light reflected from the blood to hit the phototransistor. The middle divider is constructed as a 
rectangle with dimensions of 11mm x 3.5mm x 2mm to fit between the components on the 
sensor, and the 2mm height is greater than the height of the optical components, to eliminate any 
light attenuating over.  
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Figure 5.6: Middle Divider cap design  
The “Full Cap” illustrated in figure 5.7, is constructed with the same dimensions as the PPG 
sensor, with cut outs for each of the optical components. The full cap design surrounds each 
component with a 2mm height, the cap will not only eliminate all light bleeding from the LEDs 
but also eliminate any ambient light hitting the photosensor.  
 
Figure 5.7: Final cap design 
The final test will be the PPG sensor with no physical additions to the surface, figure 5.8, this is 
the control design and there is no attempt to optimize the light attenuation. The PPG signal 




Figure 5.8: No Cap 
 
The Middle divider and the final cap design are constructed to optimize the light reaching the 
sensor. The goal is to not only increase the light attenuation into the tissues, but also the reflected 
light from the tissues to the phototransistor. These designs attempt to force the light from the 
LEDs into the tissues and eliminate bleeding of light to the phototransistor. The full cap design 
also aims to decrease any light sources in the testing area that might attempt to affect the signal 
received by the phototransistor.  
 
5.2  Test Methods  
The caps are constructed to optimize the light attenuation from the tissues to the phototransistor 
on the sensor. The goal is to increase the amount of light from the LEDs reaching the blood and 
the amount of light reflected back to the phototransistor. Each mechanical cap was added to the 
sensor and secured to ensure no movement during the testing. The right index finger was applied 
to each sensor with comparable force, and data from the PPG sensor was collected. The subject 
was asked to place a digit on the sensor for approximately 10 seconds to ensure heart rate could 
be easily identified in the signal and calculated. The signal received from the PPG sensor was not 
filtered, to allow for optimization of the raw signal. The voltage variation was analyzed to 
determine which design optimized the signal. During the testing the PPG waveform signal was 
acquired using only the IR LED, because of its higher attenuation through the tissue and stronger 
signal projection. The PPG sensor was controlled through the NI myDAQ, powering the LED 
and controlling the phototransistor. The data was collected through the myDAQ and the signal 
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was visualized using the LabVIEW software. The signal evaluated was the raw signal collected 
directly from the phototransistor, where the amplitude reflects the voltage variation.  
 
5.2 Results  
The amount of light attenuation into the tissues and reflected back to the phototransistor can be 
determined by evaluating the raw voltage signal from the PPG sensor. The waveform represents 
the blood perfusion as a result of the heartbeat, and the extent of the signal can be a result of light 
perfusion through the tissues.  
 
5.2.1 Proposed Results    
The waveform signal produced from the PPG sensor, describes how the light is attenuating 
through the tissue and reaching the phototransistor. The signal from the phototransistor is 
collected in LabVIEW and a graph of the waveform is displayed. The signal amplitude, and the 
AC signal height, range of peaks and valleys in the pulsatile signal, provide information about 
movement of light from the LEDs to the phototransistor. High amplitude signals indicate that the 
phototransistor is receiving a large quantity of light, this could be caused by high reflection of 
light off the tissue or bleeding of light from the LEDs directly to the phototransistor. On the 
contrary low amplitude signals indicate minimal light is hitting the sensor.  
 
When the light from the LEDs is hitting the tissue and reflecting back to the phototransistor, it is 
optimal, and the PPG signal will look like figure 5.9. In this graph the PPG waveform has a high 
amplitude and a high signal height. The high amplitude represents the phototransistor is 
receiving a large quantity of light, and the high signal height indicates that the light is reflected 




Figure 5.9: PPG signal with high amplitude and heigh signal height, this is the optimal signal output for a PPG sensor, because 
it reflects the light hitting the blood vessels in the tissues and reflecting back to the photosensor.   
 
In figure 5.10 the PPG signal contains a high amplitude, but the signal height is small. The high 
amplitude illustrates the high incidence of light hitting the phototransistor, but the low signal 
height indicates the light is not reflected off the blood. In this instance there is a great deal of 
light hitting the phototransistor but not a lot of the light is reflected off the blood in the tissues.  
 
 
Figure 5.10: PPG signal where the amplitude is high, but the signal height is low, indicating high amount of light reaching the 
phototransistor but not high light attenuation through the tissues. 
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If the signal received from the PPG sensor, has a low amplitude and a low signal height, seen in 
figure 5.11. In this instance the extent of light hitting the phototransistor is low, represented by 
the low amplitude, and the light that is hitting the phototransistor is not reflected off the blood in 
the tissues.  Light from the LEDs is not hitting the blood and picking up variations in blood 
volume and the phototransistor is not receiving any reflected light.  
 
 
Figure 5.11: PPG signal where the amplitude is low and the signal height is minimal, indicating less light reaching the 
phototransistor and no light attenuating through the tissue. 
 
When designing these caps, the goal is to optimize the raw signal from the phototransistor on the 
PPG sensor, to do this the signal should look like figure 5.9 where the amplitude is high, and the 
signal height is high. This signal illustrates high attenuation light through the tissues and 
increased light reflecting back to the PPG sensor.  
 
5.2.2 Design Results  
The two PPG sensor cap designs and the stand-alone PPG sensor that were tested can be seen in 
figures 5.6-8.  
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5.2.2.1 Middle Divider Cap Design  
The first cap tested was the middle divider seen in figure 5.6, the part was made to fit between 
the LEDs and the phototransistor on the PPG sensor, and block excess light hitting the 
phototransistor from the LEDs. After the LED was eliminated the index finger was placed on the 
sensor and the data from the phototransistor was collected from the myDAQ and recorded using 
the LabView software. The results can be seen in figure 5.12, the graph indicates the amplitude 
of signal is 0.1, this is the voltage that is received from the phototransistor, representing the light 
hitting the sensor. 
 
 
Figure 5.12: Middle divider cap design with an amplitude of 0.1v. 
 
5.2.2.2 Full Cap Design  
The next cap test is the full cap design, as seen in figure 5.7, is designed with the intent to fully 
encompass the sensor components. The cap is constructed to perfectly sit on top of the PPG 
sensor with cutouts for the LEDs and the phototransistor. The signal from the PPG sensor with 
the full cap design can be seen in figure 5.13, where the amplitude is low, approximately 0.05v. 
Time (s) 
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The low amplitude indicates that there is minimal light hitting the phototransistor. When looking 
at the signal height it can be concluded that there is no visible heartbeat.  
 
 
Figure 5.13: Full Cap design signal received from the PPG sensor with minimal amplitude at 0.04v. 
 
The low amplitude indicates that the light coming from the LEDs is not penetrating into the 
tissues to pick up any signal involving blood perfusion. Because the phototransistor is not 
receiving any light signal there is no indication that the LEDs are not penetrating deep enough 
into the tissues. The signal height could be non-existent in the PPG signal because no light is 
hitting the phototransistor.  
 
5.2.2.3 No Cap Design 
For comparison, the same test was performed on the PPG sensor without any cap addition, 
design illustrated in figure 5.8. The signal results for the stand-alone PPG sensor can be seen in 
figure 5.14. The figure illustrates a high amplitude, of about 0.2v this indicates the 
Time (s) 
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phototransistor is receiving high attenuation of light from the LEDs. Also indicated in figure 5.8 
is the increased signal height, which is greater than the capped sensors.  
 
 
Figure 5.14: No Cap PPG sensor signal has a high amplitude of 0.2v.  
 
The signal increase in decrease is related to the light variation from the blood volume changes. 
The raw PPG signal received when the index finger is laid directly on the PPG sensor has a high 
signal height and high amplitude, concluding the light reaching the phototransistor is reflecting 
from the vascular bed of the tissue.  
 
Comparing the amplitude results for each sensor design, the middle divider PPG signal had an 
amplitude of 0.1v, the full cap, 0.05v, and the PPG sensor with no cap was 0.2v. Figures 5.12, 
5.13 and 5.14 illustrate the amplitude recorded for the three sensors tested. The full cap design 
had the lowest amplitude indicating it was receiving the least amount of light from the LEDs, the 
middle divider had an amplitude between the full cap and no cap, thus receiving some light. The 
PPG sensor with no cap had the highest amplitude and was receiving the more from the LEDs. In 
Time (s) 
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this instance it can be concluded that the PPG sensor with no cap is the most optimal for 
receiving more light, and the addition of the cap limits the sensor’s ability to reflect and collect 
the light.  
 
Comparing the signal heights which provide some indication as to how well the LEDs are 
projecting light in the tissue, is a factor that adds to the optimization of the signal. For each cap, 
figure 5.15, shows the pulsatile signal, demonstrating the extent of light reaching and reflected 
off the vascular bed.  The full cap sensor, figure 5.15-A, has no pulsatile signal, and the 
phototransistor is not detecting light that is reflected from the blood perfusion. The middle cap 
design, figure 5.15-B indicates possible pulsatile signals from blood volume changes, the 
heartbeat is somewhat visible in the signal. The PPG sensor with no cap design, figure 5.15-A, 
has a high signal height, reflecting the light variations from the blood volume changes, the 
pulsatile PPG signal.  
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Figure 5.15: Signal height evaluation for the PPG sensor cap types. (A) the PPG sensor with no cap the correlating signal is 
significant, and the pulsatile signal can be clearly identified. (B) The PPG sensor with the middle divider, this signal contains 
minimal signal height, and the pulsatile signal can only somewhat be identified. (C) The PPG sensor with a full cap design has 
no signal height and the pulsatile signal is not present. 
 
The PPG sensor cap designs did not reflect the desired outcome, both the full cap and middle 
divider indicated low light reaching the phototransistor, and light projection from the LEDs into 
the tissues was minimal. Compared to the PPG sensor with no cap the, two cap designs did not 
optimize the signal outcome like initially intended. It was concluded that the most optimal signal 
would be produced from a PPG sensor with no cap design, and the best results would come from 
placing the tissue directly on the sensor.  
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5.3 Theory  
The question is why did the PPG sensor with no cap produce a better raw PPG signal than the 
sensors with the cap designs. The theory is skin from the fingertip is falling between the 
phototransistor and the LEDs, seen in figure 5.16. The PPG sensor is designed with 4mm of 
space between the phototransistor and the LEDs, when the subject places the finger over the 
sensor skin falls between the components.  
 
Figure 5.16: The designed PPG sensor cross section with a finger being placed over the sensor to show how the tissue of the 
finger can seep between the phototransistor (PT) and the LEDs on the sensor when there is no cap or mechanical obstruction 
between the components. 
 
This changes the PPG sensor from a reflective based PPG sensor to a transmission-based sensor, 
discussed in chapter 2.3.4. In a transmission-based sensor the light from the LEDs attenuates 
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through the tissues to the phototransistor opposite. In this case the light projected from the LEDs 
is forced to pass through the tissues and absorb into the blood, because the phototransistor is on 
the opposite side the light that is not absorbed is directly projected to the phototransistor. This 
optimizes both the light signal attenuation through the tissue, and the reflected light reaching the 
transistor. For concept to be functional the skin depth capable of fitting between the components 
must contain blood vessels with blood perfusion. The skin that the light attenuates through must 
have information about blood volume changes. To calculate if this is possible, the LED height 
and the vascular tissue bed depth must be compared.  
 
The PPG sensor that was tested is PPG sensor 2, discussed in chapter 3.2, and the optical 
components utilized are discussed in chapter 3.2.1.  Both the IR and red LED have a height of 
1.6mm and the phototransistor has a height of 1.7 mm. There are other factors such as tension 
and resistance of the skin that most likely impact the amount of tissue capable of fitting between 
the components, but the maximum, due to the optical component height, is 1.7mm. Now that the 
height of tissue that can fit between the components is determined, the depth of the skin 
containing the capillaries must be within 1.6mm. A study was completed to test the extent of skin 
thickness in response to various physical circumstances, such as vibrational and thermal signals. 
The study evaluated the thickness of the epidermis layer using an ultrasound. Although the study 
was to evaluate the difference in epidermis thickness in response to thermal and vibrational 
signals, the skin thickness throughout the study did not exceed 1mm[42]. The average skin 
epidermis thickness on the right index finger was found to be 0.57 (+- 12 SD)[42]. Because the 
depth of tissue containing capillaries is approximately 0.57mm below the skin surface (0.69mm 
at max) and the height of the optical components is 1.6mm, the skin falling between the optical 
components on the sensor is completely possible. In this case the transmission of light, through 
the vascular tissue between the optical components to the phototransistor would be more direct, 







Throughout my master’s thesis at the University of Maine, a reflective based 
photoplethysmography sensor was designed and developed. With the help of the electrical 
department and the bioengineering staff I was able to construct a working prototype capable of 
detecting heart rate and calculating blood oxygen saturation. There are a few topics I would like 
to reflect on within this project; first I would like to discuss testing that I would have performed 
had I been able to access the resources, second I will reflect on the aims of this thesis and my 
accomplishments within those aims, and finally I want to discuss future work for this device and 
potential prospective projects.  
 
6.1 Testing Intentions  
The intention was to proceed with additional testing, evaluating the heart rate and SpO2 
calculations from the designed PPG sensor to determine if the sensor was proficient. Because of 
restrictions due to the COVID-19 pandemic this testing was limited, and comparing blood 
oxygen percentages across multiple subjects was not feasible. It was intended to prove that the 
PPG sensor designed in this thesis was capable of acquiring heart rate data and calculating the 
SpO2 value, within 2% SD of SaO2 which is the claimed accuracy for most manufactured pulse 
oximeters[36]. The intention is to compare the PPG sensor’s acquired heart rate and SpO2 value 
to other on market pulse oximeters. The SpO2 value is calculated from the heart rate, which 
directly correlates to the light attenuation through the tissues and back at the sensor. The PPG 
signal result of the light projecting through the tissue and reflecting back to the photosensor is 
illustrated in figure 5.10 and defined by a height amplitude with a high signal height.  
 
6.1.1 Intended Heart Rate and SpO2 Testing Methods  
When determining the protocol for my PPG sensor evaluation I wanted to utilize similar 
techniques that have been executed in the literature, keeping in mind my intentions for the study. 
The amount of people, blood oxygen saturation, skin type, age, and health were all important 
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components to be considered when designing the study, and often incorporated into the work of 
others. Many studies compare a personally designed PPG sensor to other pulse oximeters on the 
market, as well as the results of an arterial blood gas test. Although an arterial blood gas test 
takes time, and blood oxygen saturation can change rapidly, many studies utilizing this as a 
comparative technique, record the time of blood withdrawal. Another study I found interesting, 
which tested the ability of a PPG sensor to calculate blood oxygen saturation, utilized an ice 
water bath to decrease the blood flow to the tissues[43]. This method changes the PPG signal but 
the SpO2 value and the calculation of that percentage remains constant. The study evaluates the 
accuracy of the PPG sensor when the skin temperature is colder than normal. There are many 
studies in the literature that evaluate the accuracy of PPG sensors, and after thorough research of 
many, I was able to construct a comparable testing method for the sensor designed in this thesis. 
 
The testing would have included approximately 10 subjects with SpO2 values ranging from 75% 
to 100% , similar to a study done in 2018 that compared two reflective PPG sensors at various 
locations on the body[44]. The study utilized 10 patients with various SpO2 values, ages, medical 
conditions and skin tones. The study compared the pulsatile signal of multiple PPG sensors, to 
the sensor designed in the study, by calculating and comparing the R-value. The designed sensor 
SpO2 value was also compared with the other sensors testing in this study. My intention is to 
design my study similar to this with comparable parameters and evaluation methods. 
 
Study objectives  
• The objective is to investigate feasibility of thesis designed PPG sensor by measuring 
heart rate and calculating SpO2 values taken from the foot of the patient.  
• Compare pulsatile differences between thesis designed PPG sensor and comparable 
sensors to evaluate efficiency.  
Intended Study Methods 
• Acquire information about the subject age, gender, weight, skin tone, medical conditions 
and average blood oxygen saturation.   
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• Attach designed PPG sensor to the right foot on the bottom of the big toe (figure 6.1).  
• Attach two different, commonly used transmission-based PPG sensors (pulse oximeters) 
to right and left index fingers. 
• Attach and secure reflective-based forehead PPG sensor to subject’s forehead.  
• Acquire data through the NI myDAQ and LabVIEW software for all of the sensors 
utilized in the study, for a total of 3mins.  
• Once 3mins is completed, remove all sensors 






Figure 6.1: Designed PPG sensor placed on the bottom of the big toe in the study for testing. 
 
Study Results Comparison  
To compare the performance of the designed PPG sensor to the other sensors tested the R-value 
will be calculated from the pulsatile signal. The R-value is a ratio of the peaks and valleys from 
the signal and represents the PPG waveform. The signal for all of the sensors is collected on 
LabVIEW, and the calculations of the R-value are executed in the software as well. An example 
of how this data is compared for each sensor is seen in table 6.1. The R-value is calculated by 
extracting the AC and DC component from the PPG signal and taking the ratio of the 
components with respect to the dark signal, discussed in section 2.4.3.  
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Table 6.1: Example of R-Value comparison table that would exist for the PPG sensor testing and evaluation 
 R-Value 










001     
…     
010     
 
The R-value is utilized in calculating the SpO2 values, which would also be compared for each 
one of the sensors and the arterial blood gas test, an example of this data is seen in table 6.2.  
 
Table 6.2: Example of SpO2 comparison table that would exist for the PPG sensor testing and evaluation 
 SpO2 Percentage 















001      
…      
010      
 
Further analysis of the values would be to correlate the data in a graph and evaluate the 
performance of the designed PPG sensor. The results from the PPG sensor should correlate to the 
other devices tested and no outliers or variations in the data should be apparent.  The PPG sensor 
would be deemed feasible if the sensor correlation was no greater than 2 standard deviations 
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from the correlation of the over PPG sensors. An example of the PPG sensor SpO2 valves 
compared to the other sensors across the 10 patients can be seen in figure 6.2 
 
 
Figure 6.2: An example of a graph illustrating the results of the arterial blood gas test, left pulse oximeter, right pulse oximeter, 
forehead sensor, and the designed PPG sensor SpO2, across the 10 patients 
 




	𝑋	100%     Equation 6.1 
Where the percent error is the absolute value of the experimental results minus the theoretical 
results over the theoretical result time 100. The error represents how far the expected value is 
from the tested value.  To compare the designed PPG sensor results to the other 4 methods of 
measuring blood oxygen in the study the experimental error is always the designed sensor results 
and the theoretical would be the compared sensors. Evaluation of error indicates how far the PPG 
sensor values differ from the other sensors, and example of a graph representing the percent error 




































Figure 6.3: An example of the PPG sensor’s calculated percent error of SpO2  for each patient  compared to the other sensors 
SpO2 results. 
 
6.2 Evaluation of Thesis Aims 
The first aim in this thesis was to successfully design a reflective based PPG sensor capable of 
detecting blood oxygen saturation. The PPG sensor was designed with the intention of fitting 
into the cap of the ETF (figure 5.1 and 5.2), and thus constrained inside to 13mm in diameter. 
The size restriction was one of the most difficult aspects of this project, the initial thought was to 
fit the majority of the electronic components for the PPG sensor within the cap of the EFT. This 
is seen in the initial circuit board sensor design where the resistors needed in the circuit are 
equipped on the bottom of the PPG sensor. Upon further analysis of the electronics and what 
would be needed to fit and operate in the cap of the ETF it was determined, with the help of the 
electrical engineers, that the sensor could be reduced in size if constrained to only the core 
optical components on the PCB. Because the sensor has more components than just the core 
























of the ETF cap and onto the main control board, where more electronics could be constructed for 
the device. The intention was to design and optimize the PPG sensor outside of the ETF and then 
integrate the hardware and the electrical components into the device.  
 
The second thesis aim was to optimize the PPG signal from the sensor by manipulating the 
design of the cap to enhance the light attenuation. This aim encompassed the majority of the 
work and analysis I performed with the sensor design. The intention was to optimize the PPG 
signal, as discussed in the previous sections the cap designs did not yield the initial intended 
result. The cap was initially designed to replace the entirety of the ETF cap and was constructed 
with those dimensions (figure 5.2). From the past chapters it is known that the initial caps, 
intended to replace the ETF cap, produced no signal and further design and testing was needed. 
The next stage of designs were not constructed with the intention of replacing the current EFT 
cap but to evaluate why the initial cap designs did not optimize the signal. The final caps designs 
provided useful information about the PPG sensor and its performance. It was determined that 
the signal from the PPG sensor was optimized when there was no cap or covering around the 
optical components, the PPG sensor with no cap produced the most optimal signal, and should be 
utilized as the final design in future testing. 
 
6.3 Future Work 
With the inability to complete all of the future work for this project due to time and unforeseen 
circumstances. I think it is important to express future work for this project and further 
functionality that can be incorporated into the PPG sensor and the ETF device. The intention of 
this thesis was to completely install the PPG sensor into the cap of the tuning fork. Future work 
would have encompassed installing the sensor in the ETF cap such that the installation caused no 
adverse effects to the original ETF vibrational functionality, and the PPG sensor was able to 
collect accurate data from the patient. Installing the PPG sensor into the ETF entailed working 
with the electrical engineering department to program a motherboard to control the device and 
integrate it into the ETF electronics.  
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6.3.1 Integration of Sensor into ETF 
The intention of the thesis is to incorporate the designed PPG sensor into the ETF cap. The 
intention was to design the optimal reflective based PPG sensor that is compatible with the ETF 
design, once the PPG sensor was optimized it would be integrated into the device. First the PPG 
sensor would have to be strategically incorporated in the ETF cap with wiring to the main control 
board. The sensor and the wires would have to incorporate in the device and not cause any 
negative effect on the vibrational signal. Because the goal is to take the electronic tuning fork, 
which has the ability to vibrate and test diabetic neuropathy, and add the ability to monitor blood 
oxygen saturation, any obstruction to its initial function would be adverse. The intention was to 
install the PPG sensor into the cap of the ETF with wiring that travels through the cap and up to 
the motherboard. The electronics in the motherboard of the ETF would be designed to control the 
sensor and relay SpO2 data through the ETF monitor. 
 
Future work is needed to integrate the sensor into the ETF cap. The thesis work involved, 
constructing different ETF cap designs to optimize the PPG signal, but It was determined that the 
most optimal PPG sensor was the sensor without any obstruction to the optical components. 
Work is needed to incorporate the sensor into the the ETF cap without inhibiting the emission 
and detection aspects of the sensor. Integration must involve containing the sensor within the 
ETF cap and keeping the LEDs and the photosensor exposed to be placed directly on the skin. 
The electronic tuning fork is a medical device that must be used between patients so some type 
of protective layer must be incorporated to the sensor. This protective layer will act as a barrier 
between the sensor and the tissue, but it is critical that this addition does not affect the sensor 
emissions.  
 
6.3.2 Signal Optimization for Integration  
Currently the PPG sensor is designed where the electronic components are controlled via the 
LabVIEW software and NI myDAQ but to integrate into the ETF an external motherboard would 
have to be utilized to control and collect data from the sensor. The intention was to use the NI 
myDAQ and LabVIEW software to optimize the LED control and signal manipulation for the 
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PPG sensor, and then convert that into electronics. All of the components of the sensor control 
and signal processing within the software must be analyzed to determine the most optimal 
settings for acquiring the PPG sensor. This entails optimizing; the frequency of signal 
acquisition, rate of LED state switching, length of time LED signal acquired, high pass filter, 
lowpass filter and, extent of signal collection needed for SpO2 evaluation. The LabVIEW and NI 
myDAQ control system should be utilized to evaluate the effect of changing each signal 
manipulation component.  
 
The first component is the rate of frequency of signal acquisition, this is dependent on the rate of 
acquisition of the phototransistor, and the NI myDAQ in this case. Future work will involve 
converting the signal components to electrical parts, so the frequency of acquisition will not be 
restricted to the rate of the DAQ, but rather the rate of the electrical components and 
motherboard.  
 
The next signal component to be optimized is the rate of LED switching and the time each LED 
signal should be acquired. The sample and hold technique, utilized in the PPG sensor, is 
optimized by increasing the rate of attenuation between the LED states, because the PPG signal 
will have smaller gaps in the data between “switching”. The rate at which the LEDs can be 
switched to power on and off is only restricted by the time of acquisition of the phototransistor, 
or the rise and fall time. For the particular phototransistor utilized in the sensor the rise time is 
0.11ms, and represents the time it takes for the phototransistor to respond to the light, and the fall 
time is 0.22ms and is the time it takes the phototransistor to stop responding to light. Those two 
characteristics of the phototransistor must be accounted for when optimizing the rate of the LED 
switching.  
 
Most all PPG sensors utilize high and low pass filters to extract the pulsatile signal and remove 
noise. The filters are utilized to eliminate the high and low frequency signals from the pulsatile 
signal of the heart rate. The high and low pass filters needed for a PPG sensor can be determined 
with an understanding of a normal heart rate signal. The current PPG sensor designed utilizes 
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high and low pass filters of 3Hz and 0.5Hz, respectively, and were determined as a result of 
biological heart rate. The lowpass filter at 0.5Hz would correlate to a heart rate of 30bpm, which 
is not biologically possible, and the high pass filter of 3Hz correlates to a heart rate of 180bpm. 
For future work these filters could be optimized to be more inclusive or exclusive of the PPG 
signal representing the heart rate.  
 
The final signal component is the minimum amount of data needed to calculate the SpO2. As 
discussed in previous chapters the SpO2 calculation relies on the AC and DC components of a 
PPG signal. As we know the AC and DC components of the signal correlate to the systole and 
diastole cycles of the heart beating, and thus to make one SpO2 calculation the heart must 
complete one cycle. Although this is the minimum time and signal needed to make the blood 
oxygen calculation, more data utilized for the calculation has been known to produce more 
accurate results. This is a component of the signal processing that could be optimized in future 
work to produce more accurate SpO2 results. 
 
Each signal processing component should be tested by changing their values and evaluating how 
the PPG signal amplitude, signal height and SNR change in response to the changes. The 
LabVIEW software and NI myDAQ provides easy control of the signal components allowing 
future work developing a more optimized signal. Once each component is optimized to produce 
the desired PPG signal, the control and signal manipulation, the device will be converted to 
electrical components and a central processing unit (CPU).  
 
6.3.3 Electrical Integration 
Future work will require working with the electrical engineering department to take my 
LabVIEW software and component control and build that into an external motherboard to be 
installed in the ETF. The external motherboard is capable of controlling the LEDs as well as 
acquiring and evaluation the PPG signal to calculate the SpO2 value. As I do not know much 
about the electrical conversion from signal manipulation, additional help from others with a more 
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in-depth knowledge of electronics would be needed. The components such as high pass filter and 
signal control can be built into electrical components on a PCB. Future work would involve 
investigating the most optimal way of taking the components determined from the LabVIEW 
software and converting them into electronic components that can be incorporated into the ETF 
device.  
 
The PPG sensor control and signal evaluation components would have to be combined on a 
signal PCB that could be incorporated into the ETF. This would require further evaluation of the 
ETF and how the device operates. The frequency at which the device controls the components 
would need to be determined as well as the voltage that is supplied from the batteries to the 
electrical components. The PPG installation would require variations to the sensor electronics 
depending on the supply voltage and the device frequency. Once the PPG electronics are 
optimized to incorporate with the device, further electronic integration is needed to merge the 
ETF screen to project the results from the PPG sensor. An analog to digital converter would be 
required to process the signal and produce a result that could be utilized and integrated into the 
ETF screen. 
 
6.3.4 Final Sensor Integration  
Once all aspects of the sensor have been optimized the integration into the ETF must be 
finalized. First the sensor must be mechanically integrated into the ETF cap. This includes 
installing the sensor so that the optical components are exposed on the tip of the cap. They sensor 
must fit sufficiently in the cap such that it can be placed on the tissue of a patient with mild 
pressure applied. The exposed sensor requires a covering to facilitate sanitary exchanges from 
patient to patient. The sensor covering will also illuminate electronic exposure and decrease 
failures as a result of exposure to the elements. Once integrated and the sensor signal processing 
components are optimized the sensor must be converted to a motherboard and central processing 
unit. The motherboard of the sensor must be compatible with the ETF electronics, operating at 
the same voltage, and small enough to fit within the sensor. Wiring from the PPG sensor in the 
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cap to the mother board integrated into the ETF device, must be done such that there is no effect 
on the vibrational mechanics of the tuning fork.  
 
After all of the mechanical and electrical integrations are completed the final processes requires 
alterations to the ETF. The tuning fork operates with a single function, performing the 
vibrational sensation test. The ETF must be altered to incorporate blood oxygen saturation 
monitoring functionality. Future work would involve integrating a new “Mode” into the tuning 
fork so the user could change the evaluation method. If the examiner wanted to test the blood 
oxygen saturation, there would be a button to do so and the device would turn on the sensor to 
collect PPG data. The signal acquired from the sensor would be evaluated in the ETF and 
projected on the device’s display monitor. This would be the finial component needed to 
integrate the sensor into the electronic tuning fork such that the device could monitor blood 
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